Amedeo Smart

Free Medical Literature Service

 

Amedeo

Diabetes
  Free Subscription

Articles published in
Diabetologia
    July 2024
  1. DONOVAN LE, Bell RC, Feig DS, Lemieux P, et al
    Glycaemic patterns during breastfeeding with postpartum use of closed-loop insulin delivery in women with type 1 diabetes.
    Diabetologia. 2024 Jul 19. doi: 10.1007/s00125-024-06227.
    >> Share

  2. DU S, Sullivan VK, Fang M, Appel LJ, et al
    Ultra-processed food consumption and risk of diabetes: results from a population-based prospective cohort.
    Diabetologia. 2024 Jul 13. doi: 10.1007/s00125-024-06221.
    >> Share

  3. SCULLY KJ, Marks BE, Putman MS
    Advances in diabetes technology to improve the lives of people with cystic fibrosis.
    Diabetologia. 2024 Jul 12. doi: 10.1007/s00125-024-06223.
    >> Share

  4. SCHOELWER MJ, DeBoer MD, Breton MD
    Use of diabetes technology in children.
    Diabetologia. 2024 Jul 12. doi: 10.1007/s00125-024-06218.
    >> Share

  5. WANG W, Bain SC, Bian F, Chen R, et al
    Efficacy and safety of oral semaglutide monotherapy vs placebo in a predominantly Chinese population with type 2 diabetes (PIONEER 11): a double-blind, Phase IIIa, randomised trial.
    Diabetologia. 2024 Jul 10. doi: 10.1007/s00125-024-06142.
    >> Share

  6. JI L, Agesen RM, Bain SC, Fu F, et al
    Efficacy and safety of oral semaglutide vs sitagliptin in a predominantly Chinese population with type 2 diabetes uncontrolled with metformin: PIONEER 12, a double-blind, Phase IIIa, randomised trial.
    Diabetologia. 2024 Jul 10. doi: 10.1007/s00125-024-06133.
    >> Share

  7. LUNA-MARCO C, Devos D, Cacace J, Fernandez-Reyes M, et al
    Molecular circadian clock disruption in the leukocytes of individuals with type 2 diabetes and overweight, and its relationship with leukocyte-endothelial interactions.
    Diabetologia. 2024 Jul 10. doi: 10.1007/s00125-024-06219.
    >> Share

  8. BROZZI F, Jacovetti C, Cosentino C, Menoud V, et al
    tRNA-derived fragments in T lymphocyte-beta cell crosstalk and in type 1 diabetes pathogenesis in NOD mice.
    Diabetologia. 2024 Jul 5. doi: 10.1007/s00125-024-06207.
    >> Share

  9. DE WIT DF, Fuhri Snethlage CM, Rampanelli E, Maasen K, et al
    Higher fibre and lower carbohydrate intake are associated with favourable CGM metrics in a cross-sectional cohort of 470 individuals with type 1 diabetes.
    Diabetologia. 2024 Jul 5. doi: 10.1007/s00125-024-06213.
    >> Share

  10. MCLEAN A, Maple-Brown L, Murphy HR
    Technology advances in diabetes pregnancy: right technology, right person, right time.
    Diabetologia. 2024 Jul 5. doi: 10.1007/s00125-024-06216.
    >> Share

  11. DONNELLY LA, McCrimmon RJ, Pearson ER
    Trajectories of BMI before and after diagnosis of type 2 diabetes in a real-world population.
    Diabetologia. 2024 Jul 5. doi: 10.1007/s00125-024-06217.
    >> Share

  12. THABIT H, Schofield J
    Technology in the management of diabetes in hospitalised adults.
    Diabetologia. 2024 Jul 2. doi: 10.1007/s00125-024-06206.
    >> Share


  13. Up Front.
    Diabetologia. 2024;67:1163-1164.
    >> Share

  14. GYLFE E, Tengholm A
    Bo Hellman, 19 June 1930-4 December 2023.
    Diabetologia. 2024;67:1165-1167.
    >> Share

  15. BRAKENRIDGE CJ, Koster A, de Galan BE, Carver A, et al
    Associations of 24 h time-use compositions of sitting, standing, physical activity and sleeping with optimal cardiometabolic risk and glycaemic control: The Maastricht Study.
    Diabetologia. 2024;67:1356-1367.
    >> Share

  16. HTOO PT, Tesfaye H, Schneeweiss S, Wexler DJ, et al
    Effectiveness and safety of empagliflozin: final results from the EMPRISE study.
    Diabetologia. 2024;67:1328-1342.
    >> Share

    June 2024
  17. LIARAKOS AL, Lim JZM, Leelarathna L, Wilmot EG, et al
    The use of technology in type 2 diabetes and prediabetes: a narrative review.
    Diabetologia. 2024 Jun 29. doi: 10.1007/s00125-024-06203.
    >> Share

  18. HASLAM DE, Liang L, Guo K, Martinez-Lozano M, et al
    Correction: Discovery and validation of plasma, saliva and multi-fluid plasma-saliva metabolomic scores predicting insulin resistance and diabetes progression or regression among Puerto Rican adults.
    Diabetologia. 2024 Jun 28. doi: 10.1007/s00125-024-06199.
    >> Share

  19. XIAO Q, Full KM, Rutter MK, Lipworth L, et al
    Long-term trajectories of sleep duration are associated with incident diabetes in middle-to-older-aged Black and White Americans.
    Diabetologia. 2024 Jun 27. doi: 10.1007/s00125-024-06202.
    >> Share

  20. KENNEDY B, Wernroth ML, Batra G, Hammar U, et al
    Major cardiovascular events and death in parents of children with type 1 diabetes: a register-based matched cohort study in Sweden.
    Diabetologia. 2024 Jun 26. doi: 10.1007/s00125-024-06200.
    >> Share

  21. FUHRI SNETHLAGE CM, Balvers M, Ferwerda B, Rampanelli E, et al
    Associations between diabetes-related genetic risk scores and residual beta cell function in type 1 diabetes: the GUTDM1 study.
    Diabetologia. 2024 Jun 26. doi: 10.1007/s00125-024-06204.
    >> Share

  22. BYNDLOSS M, Devkota S, Duca F, Niess JH, et al
    The gut microbiota and diabetes: research, translation, and clinical applications - 2023 Diabetes, Diabetes Care, and Diabetologia Expert Forum.
    Diabetologia. 2024 Jun 24. doi: 10.1007/s00125-024-06198.
    >> Share

  23. PHILLIP M, Achenbach P, Addala A, Albanese-O'Neill A, et al
    Consensus guidance for monitoring individuals with islet autoantibody-positive pre-stage 3 type 1 diabetes.
    Diabetologia. 2024 Jun 24. doi: 10.1007/s00125-024-06205.
    >> Share

  24. D'ALESSIO DA, Kahn SE, Mulder H
    The gut microbiota and diabetes: clarity on an emerging topic and introduction to a new partnership and journal feature.
    Diabetologia. 2024 Jun 24. doi: 10.1007/s00125-024-06208.
    >> Share

  25. UMPIERREZ GE, Davis GM, ElSayed NA, Fadini GP, et al
    Hyperglycaemic crises in adults with diabetes: a consensus report.
    Diabetologia. 2024 Jun 22. doi: 10.1007/s00125-024-06183.
    >> Share

  26. MUTHUKUMAR A, Badawy L, Mangelis A, Vas P, et al
    HbA(1c) variability is independently associated with progression of diabetic kidney disease in an urban multi-ethnic cohort of people with type 1 diabetes.
    Diabetologia. 2024 Jun 20. doi: 10.1007/s00125-024-06197.
    >> Share

  27. GAO L, Ramirez FJ, Cabrera JTO, Varghese MV, et al
    eNAMPT is a novel therapeutic target for mitigation of coronary microvascular disease in type 2 diabetes.
    Diabetologia. 2024 Jun 19. doi: 10.1007/s00125-024-06201.
    >> Share

  28. KOBAYASHI Y, Long J, Johannsen NM, Talamoa R, et al
    Is strength training more effective than aerobic exercise for improving glycaemic control and body composition in people with normal-weight type 2 diabetes? Reply to Pontes?Silva A, Santos?de?Araujo AD, Teixeira BC et al [letter].
    Diabetologia. 2024 Jun 18. doi: 10.1007/s00125-024-06181.
    >> Share

  29. WU M, Yoon CY, Park J, Kim G, et al
    The role of PCSK9 in glomerular lipid accumulation and renal injury in diabetic kidney disease.
    Diabetologia. 2024 Jun 15. doi: 10.1007/s00125-024-06191.
    >> Share

  30. MCNEILLY AD, Gallagher JR, Evans ML, de Galan BE, et al
    Correction: Chronic hyperglycaemia increases the vulnerability of the hippocampus to oxidative damage induced during post-hypoglycaemic hyperglycaemia in a mouse model of chemically induced type 1 diabetes.
    Diabetologia. 2024 Jun 12. doi: 10.1007/s00125-024-06188.
    >> Share

  31. GUDEMANN LM, Young KG, Thomas NJM, Hopkins R, et al
    Safety and effectiveness of SGLT2 inhibitors in a UK population with type 2 diabetes and aged over 70 years: an instrumental variable approach.
    Diabetologia. 2024 Jun 5. doi: 10.1007/s00125-024-06190.
    >> Share

  32. VATANEN T, de Beaufort C, Marcovecchio ML, Overbergh L, et al
    Gut microbiome shifts in people with type 1 diabetes are associated with glycaemic control: an INNODIA study.
    Diabetologia. 2024 Jun 4. doi: 10.1007/s00125-024-06192.
    >> Share

    May 2024
  33. ZHANG J, Zhang R, Liu C, Ge X, et al
    Missense mutation of ISL1 (E283D) is associated with the development of type 2 diabetes.
    Diabetologia. 2024 May 31. doi: 10.1007/s00125-024-06186.
    >> Share

  34. SINGH T, Weiss A, Vehik K, Krischer J, et al
    Caesarean section and risk of type 1 diabetes.
    Diabetologia. 2024 May 31. doi: 10.1007/s00125-024-06176.
    >> Share

  35. JEVON D, Cottle L, Hallahan N, Harwood R, et al
    Capillary contact points determine beta cell polarity, control secretion and are disrupted in the db/db mouse model of diabetes.
    Diabetologia. 2024 May 30. doi: 10.1007/s00125-024-06180.
    >> Share

  36. GROEGLER J, Callebaut A, James EA, Delong T, et al
    The insulin secretory granule is a hotspot for autoantigen formation in type 1 diabetes.
    Diabetologia. 2024 May 29. doi: 10.1007/s00125-024-06164.
    >> Share

  37. SALVATORI B, Wegener S, Kotzaeridi G, Herding A, et al
    Identification and validation of gestational diabetes subgroups by data-driven cluster analysis.
    Diabetologia. 2024 May 27. doi: 10.1007/s00125-024-06184.
    >> Share

  38. DE MEULEMEESTER J, Charleer S, Visser MM, De Block C, et al
    The association of chronic complications with time in tight range and time in range in people with type 1 diabetes: a retrospective cross-sectional real-world study.
    Diabetologia. 2024 May 24. doi: 10.1007/s00125-024-06171.
    >> Share

  39. FAGHERAZZI G, Aguayo GA, Zhang L, Hanaire H, et al
    Heterogeneity of glycaemic phenotypes in type 1 diabetes.
    Diabetologia. 2024 May 23. doi: 10.1007/s00125-024-06179.
    >> Share

  40. JUMPERTZ VON SCHWARTZENBERG R, Vazquez Arreola E, Sandforth A, Hanson RL, et al
    Role of weight loss-induced prediabetes remission in the prevention of type 2 diabetes: time to improve diabetes prevention.
    Diabetologia. 2024 May 23. doi: 10.1007/s00125-024-06178.
    >> Share

  41. HANSEN AL, Brons C, Engelhard LM, Andersen MK, et al
    Low birthweight in patients with type 2 diabetes is associated with elevated risk of cardiovascular events and mortality.
    Diabetologia. 2024 May 22. doi: 10.1007/s00125-024-06170.
    >> Share

  42. CARLTON J, Powell PA, Broadley M, de Galan BE, et al
    Development of a new health-related quality of life measure for people with diabetes who experience hypoglycaemia: the Hypo-RESOLVE QoL.
    Diabetologia. 2024 May 22. doi: 10.1007/s00125-024-06182.
    >> Share

  43. PONTES-SILVA A, Santos-de-Araujo AD, Teixeira BC, Carteri RB, et al
    Is strength training more effective than aerobic exercise for improving glycaemic control and body composition in people with normal-weight type 2 diabetes?
    Diabetologia. 2024 May 22. doi: 10.1007/s00125-024-06121.
    >> Share

  44. HASLAM DE, Liang L, Guo K, Martinez-Lozano M, et al
    Discovery and validation of plasma, saliva and multi-fluid plasma-saliva metabolomic scores predicting insulin resistance and diabetes progression or regression among Puerto Rican adults.
    Diabetologia. 2024 May 21. doi: 10.1007/s00125-024-06169.
    >> Share

  45. YUAN S, Leffler D, Lebwohl B, Green PHR, et al
    Coeliac disease and type 2 diabetes risk: a nationwide matched cohort and Mendelian randomisation study.
    Diabetologia. 2024 May 21. doi: 10.1007/s00125-024-06175.
    >> Share

  46. DEL PRATO S, Torbeyns B, Mathieu C
    2024: The year to take European action on diabetes to the next level.
    Diabetologia. 2024 May 18. doi: 10.1007/s00125-024-06166.
    >> Share

  47. SHEU A, White CP, Center JR
    Bone metabolism in diabetes: a clinician's guide to understanding the bone-glucose interplay.
    Diabetologia. 2024 May 18. doi: 10.1007/s00125-024-06172.
    >> Share

  48. IBRAHIM H, Balboa D, Saarimaki-Vire J, Montaser H, et al
    RFX6 haploinsufficiency predisposes to diabetes through impaired beta cell function.
    Diabetologia. 2024 May 14. doi: 10.1007/s00125-024-06163.
    >> Share

  49. BOUGHTON CK, Hovorka R
    The role of automated insulin delivery technology in diabetes.
    Diabetologia. 2024 May 13. doi: 10.1007/s00125-024-06165.
    >> Share

  50. CORPELEIJN WE, de Waal WJ, Schipper HS, Wiegman A, et al
    Should children with type 1 diabetes really receive statin treatment using the same criteria as for children with familial hypercholesterolaemia? Reply to Sanchez?Hernandez and Wagner [letter].
    Diabetologia. 2024 May 13. doi: 10.1007/s00125-024-06174.
    >> Share

  51. GULLAKSEN S, Vernstrom L, Sorensen SS, Ringgaard S, et al
    Correction: Separate and combined effects of semaglutide and empagliflozin on kidney oxygenation and perfusion in people with type 2 diabetes: a randomised trial.
    Diabetologia. 2024 May 13. doi: 10.1007/s00125-024-06167.
    >> Share

  52. VAN DER SCHUEREN B, Vrijlandt P, Thomson A, Janssen H, et al
    New guideline of the European Medicines Agency (EMA) on the clinical investigation of medicinal products in the treatment and prevention of diabetes mellitus.
    Diabetologia. 2024 May 4. doi: 10.1007/s00125-024-06162.
    >> Share

  53. RAUSCHER FG, Elze T, Francke M, Martinez-Perez ME, et al
    Glucose tolerance and insulin resistance/sensitivity associate with retinal layer characteristics: the LIFE-Adult-Study.
    Diabetologia. 2024;67:928-939.
    >> Share

  54. RUISSEN MM, Steyerberg EW, Huisman SD, de Graaf AA, et al
    Critical comments regarding the assessment of quality of life and the clinical impact of the POWER2DM intervention. Reply to Pouwer F, Deschenes SS [letter].
    Diabetologia. 2024;67:956-957.
    >> Share

  55. POUWER F, Deschenes S
    Critical comments regarding the assessment of quality of life and the clinical impact of the POWER2DM intervention.
    Diabetologia. 2024;67:954-955.
    >> Share

  56. IDEVALL-HAGREN O, Incedal Nilsson C, Sanchez G
    Keeping pace: the primary cilium as the conducting baton of the islet.
    Diabetologia. 2024;67:773-782.
    >> Share

    April 2024
  57. KOBAYASHI Y, Long J, Dan S, Johannsen NM, et al
    Correction to: Strength training is more effective than aerobic exercise for improving glycaemic control and body composition in people with normal-weight type 2 diabetes: a randomised controlled trial.
    Diabetologia. 2024 Apr 30. doi: 10.1007/s00125-024-06135.
    >> Share

  58. TREVISAN R, Conti M, Ciardullo S
    Once-weekly insulins: a promising approach to reduce the treatment burden in people with diabetes.
    Diabetologia. 2024 Apr 29. doi: 10.1007/s00125-024-06158.
    >> Share

  59. CHEN J, Feng Q, Qiao Y, Pan S, et al
    ACSF2 and lysine lactylation contribute to renal tubule injury in diabetes.
    Diabetologia. 2024 Apr 27. doi: 10.1007/s00125-024-06156.
    >> Share

  60. STERNER ISAKSSON S, Imberg H, Hirsch IB, Schwarcz E, et al
    Discordance between mean glucose and time in range in relation to HbA(1c) in individuals with type 1 diabetes: results from the GOLD and SILVER trials.
    Diabetologia. 2024 Apr 26. doi: 10.1007/s00125-024-06151.
    >> Share

  61. TAYLOR GS, Smith K, Scragg J, McDonald TJ, et al
    The metabolome as a diagnostic for maximal aerobic capacity during exercise in type 1 diabetes.
    Diabetologia. 2024 Apr 25. doi: 10.1007/s00125-024-06153.
    >> Share

  62. DENICOLO S, Reinstadler V, Keller F, Thoni S, et al
    Non-adherence to cardiometabolic medication as assessed by LC-MS/MS in urine and its association with kidney and cardiovascular outcomes in type 2 diabetes mellitus.
    Diabetologia. 2024 Apr 22. doi: 10.1007/s00125-024-06149.
    >> Share

  63. KIM JY, Jin SM, Sim KH, Kim BY, et al
    Continuous glucose monitoring with structured education in adults with type 2 diabetes managed by multiple daily insulin injections: a multicentre randomised controlled trial.
    Diabetologia. 2024 Apr 19. doi: 10.1007/s00125-024-06152.
    >> Share

  64. KIM JY, Jin SM, Kang ES, Kwak SH, et al
    Comparison between a tubeless, on-body automated insulin delivery system and a tubeless, on-body sensor-augmented pump in type 1 diabetes: a multicentre randomised controlled trial.
    Diabetologia. 2024 Apr 18. doi: 10.1007/s00125-024-06155.
    >> Share

  65. LI X, Donnelly LA, Slieker RC, Beulens JWJ, et al
    Trajectories of clinical characteristics, complications and treatment choices in data-driven subgroups of type 2 diabetes.
    Diabetologia. 2024 Apr 16. doi: 10.1007/s00125-024-06147.
    >> Share

  66. SACCO S, Foschi M, Ornello R, De Santis F, et al
    Prevention and treatment of ischaemic and haemorrhagic stroke in people with diabetes mellitus: a focus on glucose control and comorbidities.
    Diabetologia. 2024 Apr 16. doi: 10.1007/s00125-024-06146.
    >> Share

  67. KARAGIANNIS T, Malandris K, Avgerinos I, Stamati A, et al
    Subcutaneously administered tirzepatide vs semaglutide for adults with type 2 diabetes: a systematic review and network meta-analysis of randomised controlled trials.
    Diabetologia. 2024 Apr 13. doi: 10.1007/s00125-024-06144.
    >> Share

  68. METSALA J, Risnes K, Persson M, Veijola R, et al
    Gestational age at birth and type 1 diabetes in childhood and young adulthood: a nationwide register study in Finland, Norway and Sweden.
    Diabetologia. 2024 Apr 13. doi: 10.1007/s00125-024-06139.
    >> Share

  69. VALABHJI J, Holman N, Collins N, Young RJ, et al
    Can the introduction of a 12-lead ECG help reduce mortality in those presenting with foot ulceration to multidisciplinary diabetic foot clinics? An observational evaluation of a real-world implementation pilot in England.
    Diabetologia. 2024 Apr 8. doi: 10.1007/s00125-024-06134.
    >> Share

  70. ELEFTHERIADOU A, Riley D, Zhao SS, Austin P, et al
    Risk of diabetic retinopathy and diabetic macular oedema with sodium-glucose cotransporter 2 inhibitors and glucagon-like peptide 1 receptor agonists in type 2 diabetes: a real-world data study from a global federated database.
    Diabetologia. 2024 Apr 8. doi: 10.1007/s00125-024-06132.
    >> Share

  71. SIERRA-SILVESTRE E, Andrade RJ, Colorado LH, Edwards K, et al
    Correction to: Occurrence of corneal sub-epithelial microneuromas and axonal swelling in people with diabetes with and without (painful) diabetic neuropathy.
    Diabetologia. 2024 Apr 5. doi: 10.1007/s00125-024-06138.
    >> Share

  72. LIU B, Xie D, Huang X, Jin S, et al
    Skeletal muscle TET3 promotes insulin resistance through destabilisation of PGC-1alpha.
    Diabetologia. 2024;67:724-737.
    >> Share

  73. XIE C, Iroga P, Bound MJ, Grivell J, et al
    Impact of the timing of metformin administration on glycaemic and glucagon-like peptide-1 responses to intraduodenal glucose infusion in type 2 diabetes: a double-blind, randomised, placebo-controlled, crossover study.
    Diabetologia. 2024 Apr 1. doi: 10.1007/s00125-024-06131.
    >> Share

    March 2024
  74. KORNUM DS, Bertoli D, Kufaishi H, Wegeberg AM, et al
    Transcutaneous vagal nerve stimulation for treating gastrointestinal symptoms in individuals with diabetes: a randomised, double-blind, sham-controlled, multicentre trial.
    Diabetologia. 2024 Mar 28. doi: 10.1007/s00125-024-06129.
    >> Share

  75. VAN DEN BURG EL, Schoonakker MP, van Peet PG, van den Akker-van Marle EM, et al
    Integration of a fasting-mimicking diet programme in primary care for type 2 diabetes reduces the need for medication and improves glycaemic control: a 12-month randomised controlled trial.
    Diabetologia. 2024 Mar 28. doi: 10.1007/s00125-024-06137.
    >> Share

  76. MARCOVECCHIO ML, Hendriks AEJ, Delfin C, Battelino T, et al
    The INNODIA Type 1 Diabetes Natural History Study: a European cohort of newly diagnosed children, adolescents and adults.
    Diabetologia. 2024 Mar 22. doi: 10.1007/s00125-024-06124.
    >> Share

  77. TURNER LV, Marak MC, Gal RL, Calhoun P, et al
    Associations between daily step count classifications and continuous glucose monitoring metrics in adults with type 1 diabetes: analysis of the Type 1 Diabetes Exercise Initiative (T1DEXI) cohort.
    Diabetologia. 2024 Mar 19. doi: 10.1007/s00125-024-06127.
    >> Share

  78. LUND-BLIX NA, Bjerregaard AA, Tapia G, Stordal K, et al
    No association between long-chain n-3 fatty acid intake during pregnancy and risk of type 1 diabetes in offspring in two large Scandinavian pregnancy cohorts.
    Diabetologia. 2024 Mar 19. doi: 10.1007/s00125-024-06125.
    >> Share

  79. GUSTAFSON D, DiStefano PV, Wang XF, Wu R, et al
    Circulating small extracellular vesicles mediate vascular hyperpermeability in diabetes.
    Diabetologia. 2024 Mar 15. doi: 10.1007/s00125-024-06120.
    >> Share

  80. MONTEYNE AJ, Falkenhain K, Whelehan G, Neudorf H, et al
    A ketone monoester drink reduces postprandial blood glucose concentrations in adults with type 2 diabetes: a randomised controlled trial.
    Diabetologia. 2024 Mar 14. doi: 10.1007/s00125-024-06122.
    >> Share

  81. REGNAULT N, Lebreton E, Tang L, Fosse-Edorh S, et al
    Maternal and neonatal outcomes according to the timing of diagnosis of hyperglycaemia in pregnancy: a nationwide cross-sectional study of 695,912 deliveries in France in 2018.
    Diabetologia. 2024;67:516-527.
    >> Share

  82. GRILL V, Sorgjerd E, Hals I, Carlsson S, et al
    Comments on the notion of false positivity in measurements of autoantibodies.
    Diabetologia. 2024;67:567-568.
    >> Share

  83. GANDASI NR, Gao R, Kothegala L, Pearce A, et al
    GLP-1 metabolite GLP-1(9-36) is a systemic inhibitor of mouse and human pancreatic islet glucagon secretion.
    Diabetologia. 2024;67:528-546.
    >> Share

  84. HEIANZA Y, Zhou T, Wang X, Furtado JD, et al
    MTNR1B genotype and effects of carbohydrate quantity and dietary glycaemic index on glycaemic response to an oral glucose load: the OmniCarb trial.
    Diabetologia. 2024;67:506-515.
    >> Share

  85. SHE R, Suvitaival T, Andersen HU, Hommel E, et al
    Metabolic effect of adrenaline infusion in people with type 1 diabetes and healthy individuals.
    Diabetologia. 2024 Mar 1. doi: 10.1007/s00125-024-06116.
    >> Share

    February 2024
  86. SU M, Hou Y, Cai S, Li W, et al
    Elevated ITGA1 levels in type 2 diabetes: implications for cardiac function impairment.
    Diabetologia. 2024 Feb 27. doi: 10.1007/s00125-024-06109.
    >> Share

  87. JIN Q, Lau ESH, Luk AO, Tam CHT, et al
    Circulating metabolomic markers linking diabetic kidney disease and incident cardiovascular disease in type 2 diabetes: analyses from the Hong Kong Diabetes Biobank.
    Diabetologia. 2024 Feb 27. doi: 10.1007/s00125-024-06108.
    >> Share

  88. REUTRAKUL S, Park JC, McAnany JJ, Chau FY, et al
    Dysregulated 24 h melatonin secretion associated with intrinsically photosensitive retinal ganglion cell function in diabetic retinopathy: a cross-sectional study.
    Diabetologia. 2024 Feb 27. doi: 10.1007/s00125-024-06118.
    >> Share

  89. TER BRAAKE JG, Fleetwood KJ, Vos RC, Blackbourn L, et al
    Cardiovascular risk management among individuals with type 2 diabetes and severe mental illness: a cohort study.
    Diabetologia. 2024 Feb 26. doi: 10.1007/s00125-024-06111.
    >> Share

  90. COOMANS DE BRACHENE A, Alvelos MI, Szymczak F, Zimath PL, et al
    Interferons are key cytokines acting on pancreatic islets in type 1 diabetes.
    Diabetologia. 2024 Feb 26. doi: 10.1007/s00125-024-06106.
    >> Share

  91. LEHNER CT, Eberl M, Donnachie E, Tanaka LF, et al
    Incidence trend of type 2 diabetes from 2012 to 2021 in Germany: an analysis of health claims data of 11 million statutorily insured people.
    Diabetologia. 2024 Feb 26. doi: 10.1007/s00125-024-06113.
    >> Share

  92. SANCHEZ-HERNANDEZ RM, Wagner AM
    Should children with type 1 diabetes really receive statin treatment using the same criteria as for children with familial hypercholesterolaemia?
    Diabetologia. 2024 Feb 26. doi: 10.1007/s00125-024-06115.
    >> Share

  93. BASSET-SAGARMINAGA J, van de Weijer T, Iozzo P, Schrauwen P, et al
    Correction to: Advances and challenges in measuring hepatic glucose uptake with FDG PET: implications for diabetes research.
    Diabetologia. 2024 Feb 23. doi: 10.1007/s00125-024-06112.
    >> Share

  94. CARDOSO P, Young KG, Nair ATN, Hopkins R, et al
    Phenotype-based targeted treatment of SGLT2 inhibitors and GLP-1 receptor agonists in type 2 diabetes.
    Diabetologia. 2024 Feb 22. doi: 10.1007/s00125-024-06099.
    >> Share

  95. CELIND J, Bygdell M, Bramsved R, Martikainen J, et al
    Low birthweight and overweight during childhood and young adulthood and the risk of type 2 diabetes in men: a population-based cohort study.
    Diabetologia. 2024 Feb 22. doi: 10.1007/s00125-024-06101.
    >> Share

  96. BELIARD S, Mourre F, Valero R
    Hyperlipidaemia in diabetes: are there particular considerations for next-generation therapies?
    Diabetologia. 2024 Feb 20. doi: 10.1007/s00125-024-06100.
    >> Share

  97. HOLT RIG, Cockram CS, Ma RCW, Luk AOY, et al
    Diabetes and infection: review of the epidemiology, mechanisms and principles of treatment.
    Diabetologia. 2024 Feb 20. doi: 10.1007/s00125-024-06102.
    >> Share

  98. SLIEKER RC, Munch M, Donnelly LA, Bouland GA, et al
    An omics-based machine learning approach to predict diabetes progression: a RHAPSODY study.
    Diabetologia. 2024 Feb 19. doi: 10.1007/s00125-024-06105.
    >> Share

  99. ZHEN J, Gu Y, Wang P, Wang W, et al
    Genome-wide association and Mendelian randomisation analysis among 30,699 Chinese pregnant women identifies novel genetic and molecular risk factors for gestational diabetes and glycaemic traits.
    Diabetologia. 2024 Feb 19. doi: 10.1007/s00125-023-06065.
    >> Share

  100. HYOTY H, Kaariainen S, Laiho JE, Comer GM, et al
    Safety, tolerability and immunogenicity of PRV-101, a multivalent vaccine targeting coxsackie B viruses (CVBs) associated with type 1 diabetes: a double-blind randomised placebo-controlled Phase I trial.
    Diabetologia. 2024 Feb 19. doi: 10.1007/s00125-024-06092.
    >> Share

  101. LEE K, Kuang A, Bain JR, Hayes MG, et al
    Metabolomic and genetic architecture of gestational diabetes subtypes.
    Diabetologia. 2024 Feb 17. doi: 10.1007/s00125-024-06110.
    >> Share

  102. VEDOVATO N, Salguero MV, Greeley SAW, Yu CH, et al
    A loss-of-function mutation in KCNJ11 causing sulfonylurea-sensitive diabetes in early adult life.
    Diabetologia. 2024 Feb 17. doi: 10.1007/s00125-024-06103.
    >> Share

  103. JANCEV M, Vissers TACM, Visseren FLJ, van Bon AC, et al
    Continuous glucose monitoring in adults with type 2 diabetes: a systematic review and meta-analysis.
    Diabetologia. 2024 Feb 16. doi: 10.1007/s00125-024-06107.
    >> Share

  104. KENGNE AP, Ramachandran A
    Feasibility of prevention of type 2 diabetes in low- and middle-income countries.
    Diabetologia. 2024 Feb 15. doi: 10.1007/s00125-023-06085.
    >> Share

  105. TEIXEIRA PF, Battelino T, Carlsson A, Gudbjornsdottir S, et al
    Assisting the implementation of screening for type 1 diabetes by using artificial intelligence on publicly available data.
    Diabetologia. 2024 Feb 14. doi: 10.1007/s00125-024-06089.
    >> Share

  106. BLUHER M, Rosenstock J, Hoefler J, Manuel R, et al
    Correction to: Dose-response effects on HbA(1c) and bodyweight reduction of survodutide, a dual glucagon/GLP-1 receptor agonist, compared with placebo and open-label semaglutide in people with type 2 diabetes: a randomised clinical trial.
    Diabetologia. 2024 Feb 13. doi: 10.1007/s00125-024-06095.
    >> Share

  107. GUO M, Guo H, Zhu J, Wang F, et al
    A novel subpopulation of monocytes with a strong interferon signature indicated by SIGLEC-1 is present in patients with in recent-onset type 1 diabetes.
    Diabetologia. 2024 Feb 13. doi: 10.1007/s00125-024-06098.
    >> Share

  108. KURGAN N, Kjaergaard Larsen J, Deshmukh AS
    Harnessing the power of proteomics in precision diabetes medicine.
    Diabetologia. 2024 Feb 12. doi: 10.1007/s00125-024-06097.
    >> Share

  109. HOEK AG, Dal Canto E, Wenker E, Bindraban N, et al
    Epidemiology of heart failure in diabetes: a disease in disguise.
    Diabetologia. 2024 Feb 9. doi: 10.1007/s00125-023-06068.
    >> Share

  110. QADRI S, Yki-Jarvinen H
    Surveillance of the liver in type 2 diabetes: important but unfeasible?
    Diabetologia. 2024 Feb 9. doi: 10.1007/s00125-024-06087.
    >> Share

  111. SAVARESE G, Lindberg F, Filippatos G, Butler J, et al
    Mineralocorticoid receptor overactivation: targeting systemic impact with non-steroidal mineralocorticoid receptor antagonists.
    Diabetologia. 2024;67:246-262.
    >> Share

  112. MISKELLY MG, Lindqvist A, Piccinin E, Hamilton A, et al
    RNA sequencing unravels novel L cell constituents and mechanisms of GLP-1 secretion in human gastric bypass-operated intestine.
    Diabetologia. 2024;67:356-370.
    >> Share

  113. TANNER HL, Ng HT, Murphy G, Barrett HL, et al
    Habitual carbohydrate intake is not correlated with circulating beta-hydroxybutyrate levels in pregnant women with overweight and obesity at 28 weeks' gestation.
    Diabetologia. 2024;67:346-355.
    >> Share

    January 2024
  114. ASEMI Z, Karamali M, Esmaillzadeh A
    Editorial Expression of Concern: Effects of calcium-vitamin D co-supplementation on glycaemic control, inflammation and oxidative stress in gestational diabetes: a randomised placebo-controlled trial.
    Diabetologia. 2024 Jan 30. doi: 10.1007/s00125-023-06077.
    >> Share

  115. GARCIA R, Schroder LC, Tavernier M, Gand E, et al
    QRS-T angle: is it a specific parameter associated with sudden cardiac death in type 2 diabetes? Results from the SURDIAGENE and the Mini-Finland prospective cohorts.
    Diabetologia. 2024 Jan 24. doi: 10.1007/s00125-023-06074.
    >> Share

  116. SAMUELSSON J, Bertilsson R, Bulow E, Carlsson S, et al
    Autoimmune comorbidity in type 1 diabetes and its association with metabolic control and mortality risk in young people: a population-based study.
    Diabetologia. 2024 Jan 22. doi: 10.1007/s00125-024-06086.
    >> Share

  117. RAUBENHEIMER PJ, Skelton J, Peya B, Dave JA, et al
    Phenotype and predictors of insulin independence in adults presenting with diabetic ketoacidosis: a prospective cohort study.
    Diabetologia. 2024 Jan 19. doi: 10.1007/s00125-023-06067.
    >> Share

  118. SHAO M, Chen D, Wang Q, Guo F, et al
    Canagliflozin regulates metabolic reprogramming in diabetic kidney disease by inducing fasting-like and aestivation-like metabolic patterns.
    Diabetologia. 2024 Jan 18. doi: 10.1007/s00125-023-06078.
    >> Share

  119. VISSER MM, Van Muylder A, Charleer S, Isitt JJ, et al
    Cost-utility analysis of Dexcom G6 real-time continuous glucose monitoring versus FreeStyle Libre 1 intermittently scanned continuous glucose monitoring in adults with type 1 diabetes in Belgium.
    Diabetologia. 2024 Jan 18. doi: 10.1007/s00125-023-06084.
    >> Share

  120. TUOMELA K, Levings MK
    Genetic engineering of regulatory T cells for treatment of autoimmune disorders including type 1 diabetes.
    Diabetologia. 2024 Jan 18. doi: 10.1007/s00125-023-06076.
    >> Share

  121. GREGG EW, Chen H, Bancks MP, Manalac R, et al
    Impact of remission from type 2 diabetes on long-term health outcomes: findings from the Look AHEAD study.
    Diabetologia. 2024 Jan 18. doi: 10.1007/s00125-023-06048.
    >> Share

  122. ALZUBAIDI H, Oliveira VH, Samorinha C, Mc Namara K, et al
    Acculturation and glycaemic control in Arab immigrants with type 2 diabetes in Australia.
    Diabetologia. 2024 Jan 12. doi: 10.1007/s00125-023-06081.
    >> Share

  123. BRUZZANITI S, Piemonte E, Bruzzese D, Lepore MT, et al
    Progression of type 1 diabetes is associated with high levels of soluble PD-1 in islet autoantibody-positive children.
    Diabetologia. 2024 Jan 12. doi: 10.1007/s00125-023-06075.
    >> Share

  124. HUMMEL S, Rosenberger S, von dem Berge T, Besser REJ, et al
    Early-childhood body mass index and its association with the COVID-19 pandemic, containment measures and islet autoimmunity in children with increased risk for type 1 diabetes.
    Diabetologia. 2024 Jan 12. doi: 10.1007/s00125-023-06079.
    >> Share

  125. CASTILLO-ARMENGOL J, Marzetta F, Sanchez-Archidona AR, Fledelius C, et al
    Correction to: Disrupted hypothalamic transcriptomics and proteomics in a mouse model of type 2 diabetes exposed to recurrent hypoglycaemia.
    Diabetologia. 2024 Jan 11. doi: 10.1007/s00125-023-06083.
    >> Share

  126. WERKMAN NCC, Garcia-Saez G, Nielen JTH, Tapia-Galisteo J, et al
    Disease severity-based subgrouping of type 2 diabetes does not parallel differences in quality of life: the Maastricht Study.
    Diabetologia. 2024 Jan 11. doi: 10.1007/s00125-023-06082.
    >> Share

  127. DHANAPALARATNAM R, Issar T, Lee ATK, Poynten AM, et al
    Glucagon-like peptide-1 receptor agonists reverse nerve morphological abnormalities in diabetic peripheral neuropathy.
    Diabetologia. 2024 Jan 8. doi: 10.1007/s00125-023-06072.
    >> Share

  128. ROTHBERG A, Lean M, Laferrere B
    Remission of type 2 diabetes: always more questions, but enough answers for action.
    Diabetologia. 2024 Jan 8. doi: 10.1007/s00125-023-06069.
    >> Share

  129. FERNANDEZ-VELEDO S, Marsal-Beltran A, Vendrell J
    Type 2 diabetes and succinate: unmasking an age-old molecule.
    Diabetologia. 2024 Jan 5. doi: 10.1007/s00125-023-06063.
    >> Share

  130. AHMED R, de Souza RJ, Li V, Banfield L, et al
    Twenty years of participation of racialised groups in type 2 diabetes randomised clinical trials: a meta-epidemiological review.
    Diabetologia. 2024 Jan 4. doi: 10.1007/s00125-023-06052.
    >> Share

  131. PENALVO JL
    The impact of taxing sugar-sweetened beverages on diabetes: a critical review.
    Diabetologia. 2024 Jan 4. doi: 10.1007/s00125-023-06064.
    >> Share

  132. PAZ-BARBA M, Munoz Garcia A, de Winter TJJ, de Graaf N, et al
    Apolipoprotein L genes are novel mediators of inflammation in beta cells.
    Diabetologia. 2024;67:124-136.
    >> Share

  133. REN L, Charbord J, Chu L, Kemas AM, et al
    Adjudin improves beta cell maturation, hepatic glucose uptake and glucose homeostasis.
    Diabetologia. 2024;67:137-155.
    >> Share

  134. CHHABRA KH, Bathina S, Faniyan TS, Samuel DJ, et al
    ADGRL1 is a glucose receptor involved in mediating energy and glucose homeostasis.
    Diabetologia. 2024;67:170-189.
    >> Share

    December 2023
  135. KRISHNAN A, Schneider CV, Hadi Y, Mukherjee D, et al
    Cardiovascular and mortality outcomes with GLP-1 receptor agonists vs other glucose-lowering drugs in individuals with NAFLD and type 2 diabetes: a large population-based matched cohort study.
    Diabetologia. 2023 Dec 20. doi: 10.1007/s00125-023-06057.
    >> Share

  136. BASSET-SAGARMINAGA J, van de Weijer T, Iozzo P, Schrauwen P, et al
    Advances and challenges in measuring hepatic glucose uptake with FDG PET: implications for diabetes research.
    Diabetologia. 2023 Dec 15. doi: 10.1007/s00125-023-06055.
    >> Share

  137. EMANUELSSON F, Afzal S, Jorgensen NR, Nordestgaard BG, et al
    Hyperglycaemia, diabetes and risk of fragility fractures: observational and Mendelian randomisation studies.
    Diabetologia. 2023 Dec 14. doi: 10.1007/s00125-023-06054.
    >> Share

  138. BLUHER M, Rosenstock J, Hoefler J, Manuel R, et al
    Dose-response effects on HbA(1c) and bodyweight reduction of survodutide, a dual glucagon/GLP-1 receptor agonist, compared with placebo and open-label semaglutide in people with type 2 diabetes: a randomised clinical trial.
    Diabetologia. 2023 Dec 14. doi: 10.1007/s00125-023-06053.
    >> Share

  139. CARRASQUILLA GD, Angquist L, Sorensen TIA, Kilpelainen TO, et al
    Child-to-adult body size change and risk of type 2 diabetes and cardiovascular disease.
    Diabetologia. 2023 Dec 12. doi: 10.1007/s00125-023-06058.
    >> Share

  140. MEULEBROUCK S, Scherrer V, Boutry R, Toussaint B, et al
    Pathogenic monoallelic variants in GLIS3 increase type 2 diabetes risk and identify a subgroup of patients sensitive to sulfonylureas.
    Diabetologia. 2023 Dec 5. doi: 10.1007/s00125-023-06035.
    >> Share

  141. JENDLE J, Adolfsson P, Choudhary P, Dovc K, et al
    A narrative commentary about interoperability in medical devices and data used in diabetes therapy from an academic EU/UK/US perspective.
    Diabetologia. 2023 Dec 2. doi: 10.1007/s00125-023-06049.
    >> Share

  142. CROMER SJ, Thaweethai T, Wexler DJ
    Racial/ethnic and socioeconomic disparities in achievement of treatment goals within a clinical trial: a secondary analysis of the ACCORD trial.
    Diabetologia. 2023;66:2261-2274.
    >> Share

    November 2023
  143. CORPELEIJN WE, de Waal WJ, Schipper HS, Wiegman A, et al
    Dyslipidaemia as a target for atherosclerotic cardiovascular disease prevention in children with type 1 diabetes: lessons learned from familial hypercholesterolaemia.
    Diabetologia. 2023 Nov 30. doi: 10.1007/s00125-023-06041.
    >> Share

  144. GAJECKA M, Gutaj P, Jaskiewicz K, Rydzanicz M, et al
    Effects of maternal type 1 diabetes and confounding factors on neonatal microbiomes.
    Diabetologia. 2023 Nov 29. doi: 10.1007/s00125-023-06047.
    >> Share

  145. MOOSHAGE CM, Tsilingiris D, Schimpfle L, Seebauer L, et al
    A diminished sciatic nerve structural integrity is associated with distinct peripheral sensory phenotypes in individuals with type 2 diabetes.
    Diabetologia. 2023 Nov 29. doi: 10.1007/s00125-023-06050.
    >> Share

  146. CASTILLO-ARMENGOL J, Marzetta F, Rodriguez Sanchez-Archidona A, Fledelius C, et al
    Disrupted hypothalamic transcriptomics and proteomics in a mouse model of type 2 diabetes exposed to recurrent hypoglycaemia.
    Diabetologia. 2023 Nov 28. doi: 10.1007/s00125-023-06043.
    >> Share

  147. FARRELL CM, McNeilly AD, Hapca S, Fournier PA, et al
    High intensity interval training as a novel treatment for impaired awareness of hypoglycaemia in people with type 1 diabetes (HIT4HYPOS): a randomised parallel-group study.
    Diabetologia. 2023 Nov 27. doi: 10.1007/s00125-023-06051.
    >> Share

  148. MACKENZIE SC, Sainsbury CAR, Wake DJ
    Diabetes and artificial intelligence beyond the closed loop: a review of the landscape, promise and challenges.
    Diabetologia. 2023 Nov 18. doi: 10.1007/s00125-023-06038.
    >> Share

  149. TRICO D, Masoni MC, Baldi S, Cimbalo N, et al
    Early time-restricted carbohydrate consumption vs conventional dieting in type 2 diabetes: a randomised controlled trial.
    Diabetologia. 2023 Nov 16. doi: 10.1007/s00125-023-06045.
    >> Share

  150. VYAKARANAM AR, Mahamed MM, Hellman P, Eriksson O, et al
    Non-invasive imaging of sympathetic innervation of the pancreas in individuals with type 2 diabetes.
    Diabetologia. 2023 Nov 7. doi: 10.1007/s00125-023-06039.
    >> Share

  151. DRENTHEN LCA, de Baaij JHF, Rodwell L, van Herwaarden AE, et al
    Oral magnesium supplementation does not affect insulin sensitivity in people with insulin-treated type 2 diabetes and a low serum magnesium: a randomised controlled trial.
    Diabetologia. 2023 Nov 3. doi: 10.1007/s00125-023-06029.
    >> Share

  152. PETRELLI A, Cugnata F, Carnovale D, Bosi E, et al
    HOMA-IR and the Matsuda Index as predictors of progression to type 1 diabetes in autoantibody-positive relatives.
    Diabetologia. 2023 Nov 2. doi: 10.1007/s00125-023-06034.
    >> Share

  153. HUGHES AE, Houghton JAL, Bunce B, Chakera AJ, et al
    Bringing precision medicine to the management of pregnancy in women with glucokinase-MODY: a study of diagnostic accuracy and feasibility of non-invasive prenatal testing.
    Diabetologia. 2023;66:1997-2006.
    >> Share

  154. YAVOROV-DAYLIEV D, Milagro FI, Ayo J, Oneca M, et al
    Glucose-lowering effects of a synbiotic combination containing Pediococcus acidilactici in C. elegans and mice.
    Diabetologia. 2023;66:2117-2138.
    >> Share

  155. THOMAIDOU S, Munoz Garcia A, de Lange S, Gan J, et al
    IFN? but not IFNalpha increases recognition of insulin defective ribosomal product-derived antigen to amplify islet autoimmunity.
    Diabetologia. 2023;66:2075-2086.
    >> Share

  156. IIDA H, Kono T, Lee CC, Krishnan P, et al
    SERCA2 regulates proinsulin processing and processing enzyme maturation in pancreatic beta cells.
    Diabetologia. 2023;66:2042-2061.
    >> Share

  157. SKRIVER C, Friis S, Knudsen LB, Catarig AM, et al
    Potential preventive properties of GLP-1 receptor agonists against prostate cancer: a nationwide cohort study.
    Diabetologia. 2023;66:2007-2016.
    >> Share

    October 2023
  158. DE HASE EM, Neyrinck AM, Rodriguez J, Cnop M, et al
    Impact of metformin and Dysosmobacter welbionis on diet-induced obesity and diabetes: from clinical observation to preclinical intervention.
    Diabetologia. 2023 Oct 28. doi: 10.1007/s00125-023-06032.
    >> Share

  159. AMARATUNGA SA, Hussein Tayeb T, Muhamad Sediq RN, Hama Salih FK, et al
    Paediatric diabetes subtypes in a consanguineous population: a single-centre cohort study from Kurdistan, Iraq.
    Diabetologia. 2023 Oct 28. doi: 10.1007/s00125-023-06030.
    >> Share

  160. CARRASCO-ZANINI J, Pietzner M, Wheeler E, Kerrison ND, et al
    Multi-omic prediction of incident type 2 diabetes.
    Diabetologia. 2023 Oct 27. doi: 10.1007/s00125-023-06027.
    >> Share

  161. ZHONG T, He B, Li X, Lei K, et al
    Glycaemia risk index uncovers distinct glycaemic variability patterns associated with remission status in type 1 diabetes.
    Diabetologia. 2023 Oct 27. doi: 10.1007/s00125-023-06042.
    >> Share

  162. HATANO Y, VanWagner LB, Carnethon MR, Bancks MP, et al
    Using race as a social construct when looking at differences in racial associations between non?alcoholic fatty liver disease and type 2 diabetes. Reply to Rollin FG, Washington C, Fluker S-A [letter].
    Diabetologia. 2023 Oct 26. doi: 10.1007/s00125-023-06024.
    >> Share

  163. CORBIN LJ, Hughes DA, Bull CJ, Vincent EE, et al
    The metabolomic signature of weight loss and remission in the Diabetes Remission Clinical Trial (DiRECT).
    Diabetologia. 2023 Oct 25. doi: 10.1007/s00125-023-06019.
    >> Share

  164. BOWDEN N, Dixon R, Anderson V, de Bock M, et al
    Associations between type 1 diabetes and educational outcomes: an Aotearoa/New Zealand nationwide birth cohort study using the Integrated Data Infrastructure.
    Diabetologia. 2023 Oct 23. doi: 10.1007/s00125-023-06026.
    >> Share

  165. ELLIOTT J, Sloan G, Stevens L, Selvarajah D, et al
    Female sex is a risk factor for painful diabetic peripheral neuropathy: the EURODIAB prospective diabetes complications study.
    Diabetologia. 2023 Oct 23. doi: 10.1007/s00125-023-06025.
    >> Share

  166. LEE DH, Jin Q, Shi N, Wang F, et al
    The metabolic potential of inflammatory and insulinaemic dietary patterns and risk of type 2 diabetes.
    Diabetologia. 2023 Oct 11. doi: 10.1007/s00125-023-06021.
    >> Share

  167. SRIDHAR VS, Limonte CP, Groop PH, Heerspink HJL, et al
    Chronic kidney disease in type 1 diabetes: translation of novel type 2 diabetes therapeutics to individuals with type 1 diabetes.
    Diabetologia. 2023 Oct 6. doi: 10.1007/s00125-023-06015.
    >> Share

  168. SVALASTOGA P, Kaci A, Molnes J, Solheim MH, et al
    Characterisation of HNF1A variants in paediatric diabetes in Norway using functional and clinical investigations to unmask phenotype and monogenic diabetes.
    Diabetologia. 2023 Oct 5. doi: 10.1007/s00125-023-06012.
    >> Share

  169. YARDLEY JE, Govette A, Laesser CI, Lespagnol E, et al
    Sex influences health: reporting on female characteristics should be mandatory in exercise and physical activity-related diabetes research.
    Diabetologia. 2023 Oct 5. doi: 10.1007/s00125-023-06022.
    >> Share

  170. MATHIEU C, Wiedeman A, Cerosaletti K, Long SA, et al
    A first-in-human, open-label Phase 1b and a randomised, double-blind Phase 2a clinical trial in recent-onset type 1 diabetes with AG019 as monotherapy and in combination with teplizumab.
    Diabetologia. 2023 Oct 2. doi: 10.1007/s00125-023-06014.
    >> Share

  171. ANDREASEN CR, Andersen A, Vilsboll T
    The future of incretins in the treatment of obesity and non-alcoholic fatty liver disease.
    Diabetologia. 2023;66:1846-1858.
    >> Share

  172. KARAGIANNIS T, Bekiari E, Tsapas A
    Socioeconomic aspects of incretin-based therapy.
    Diabetologia. 2023;66:1859-1868.
    >> Share

  173. TSCHOP M, Nogueiras R, Ahren B
    Gut hormone-based pharmacology: novel formulations and future possibilities for metabolic disease therapy.
    Diabetologia. 2023;66:1796-1808.
    >> Share

  174. DRUCKER DJ, Holst JJ
    The expanding incretin universe: from basic biology to clinical translation.
    Diabetologia. 2023;66:1765-1779.
    >> Share

    September 2023
  175. WADSTROM BN, Pedersen KM, Wulff AB, Nordestgaard BG, et al
    Elevated remnant cholesterol and atherosclerotic cardiovascular disease in diabetes: a population-based prospective cohort study.
    Diabetologia. 2023 Sep 30. doi: 10.1007/s00125-023-06016.
    >> Share

  176. TASKINEN MR, Matikainen N, Bjornson E, Soderlund S, et al
    Contribution of intestinal triglyceride-rich lipoproteins to residual atherosclerotic cardiovascular disease risk in individuals with type 2 diabetes on statin therapy.
    Diabetologia. 2023 Sep 29. doi: 10.1007/s00125-023-06008.
    >> Share

  177. RUISSEN MM, Torres-Pena JD, Uitbeijerse BS, Arenas de Larriva AP, et al
    Clinical impact of an integrated e-health system for diabetes self-management support and shared decision making (POWER2DM): a randomised controlled trial.
    Diabetologia. 2023 Sep 29. doi: 10.1007/s00125-023-06006.
    >> Share

  178. MITA T, Katakami N, Okada Y, Yoshii H, et al
    Continuous glucose monitoring-derived time in range and CV are associated with altered tissue characteristics of the carotid artery wall in people with type 2 diabetes.
    Diabetologia. 2023 Sep 26. doi: 10.1007/s00125-023-06013.
    >> Share

  179. SCHNEIDER J, Gemulla G, Kiess W, Berner R, et al
    Presymptomatic type 1 diabetes and disease severity at onset.
    Diabetologia. 2023 Sep 26. doi: 10.1007/s00125-023-05999.
    >> Share

  180. THOMAS NJ, Jones AG
    The challenges of identifying and studying type 1 diabetes in adults.
    Diabetologia. 2023 Sep 20. doi: 10.1007/s00125-023-06004.
    >> Share

  181. HU X, Buhl CS, Sjogaard MB, Schousboe K, et al
    Structural changes in Schwann cells and nerve fibres in type 1 diabetes: relationship with diabetic polyneuropathy.
    Diabetologia. 2023 Sep 20. doi: 10.1007/s00125-023-06009.
    >> Share

  182. TIAN C, Burki C, Westerman KE, Patel CJ, et al
    Association between timing and consistency of physical activity and type 2 diabetes: a cohort study on participants of the UK Biobank.
    Diabetologia. 2023 Sep 20. doi: 10.1007/s00125-023-06001.
    >> Share

  183. WRIGHT DM, Chakravarthy U, Das R, Graham KW, et al
    Identifying the severity of diabetic retinopathy by visual function measures using both traditional statistical methods and interpretable machine learning: a cross-sectional study.
    Diabetologia. 2023 Sep 19. doi: 10.1007/s00125-023-06005.
    >> Share

  184. HUMMEL S, Friedl N, Winkler C, Ziegler AG, et al
    Presymptomatic type 1 diabetes and disease severity at onset. Reply to Schneider J, Gemulla G, Kiess W et al [letter].
    Diabetologia. 2023 Sep 19. doi: 10.1007/s00125-023-06017.
    >> Share

  185. GALDERISI A, Carr ALJ, Martino M, Taylor P, et al
    Quantifying beta cell function in the preclinical stages of type 1 diabetes.
    Diabetologia. 2023 Sep 15. doi: 10.1007/s00125-023-06011.
    >> Share

  186. BONORA BM, Morieri ML, Marassi M, Cappellari R, et al
    Improved prediction of long-term kidney outcomes in people with type 2 diabetes by levels of circulating haematopoietic stem/progenitor cells.
    Diabetologia. 2023 Sep 15. doi: 10.1007/s00125-023-06002.
    >> Share

  187. ROLLIN FG, Washington C, Fluker SA
    Using race as a social construct when looking at differences in racial associations between non-alcoholic fatty liver disease and type 2 diabetes.
    Diabetologia. 2023 Sep 7. doi: 10.1007/s00125-023-05998.
    >> Share

  188. DHARMARAJAN S, Carrillo C, Qi Z, Wilson JM, et al
    Retinal inflammation in murine models of type 1 and type 2 diabetes with diabetic retinopathy.
    Diabetologia. 2023 Sep 5. doi: 10.1007/s00125-023-05995.
    >> Share

  189. SIMS EK, Geyer SM, Long SA, Herold KC, et al
    High proinsulin:C-peptide ratio identifies individuals with stage 2 type 1 diabetes at high risk for progression to clinical diagnosis and responses to teplizumab treatment.
    Diabetologia. 2023 Sep 4. doi: 10.1007/s00125-023-06003.
    >> Share


  190. 59(th) EASD Annual Meeting of the European Association for the Study of Diabetes : Hamburg, Germany, 2 - 6 October 2023.
    Diabetologia. 2023 Sep 4. doi: 10.1007/s00125-023-05969.
    >> Share

    August 2023
  191. LI JM, Li X, Chan LWC, Hu R, et al
    Lipotoxicity-polarised macrophage-derived exosomes regulate mitochondrial fitness through Miro1-mediated mitophagy inhibition and contribute to type 2 diabetes development in mice.
    Diabetologia. 2023 Aug 24. doi: 10.1007/s00125-023-05992.
    >> Share

  192. MEEK CL, Stewart ZA, Feig DS, Furse S, et al
    Metabolomic insights into maternal and neonatal complications in pregnancies affected by type 1 diabetes.
    Diabetologia. 2023 Aug 24. doi: 10.1007/s00125-023-05989.
    >> Share

  193. RETNAKARAN R, Ye C, Kramer CK, Hanley AJ, et al
    Deteriorating beta cell function is the dominant determinant of progression from normal glucose tolerance to prediabetes/diabetes in young women following pregnancy.
    Diabetologia. 2023 Aug 24. doi: 10.1007/s00125-023-05994.
    >> Share

  194. GOLDNEY J, Sargeant JA, Davies MJ
    Incretins and microvascular complications of diabetes: neuropathy, nephropathy, retinopathy and microangiopathy.
    Diabetologia. 2023 Aug 19. doi: 10.1007/s00125-023-05988.
    >> Share

  195. MOKHTAR SBA, van der Heide FCT, Oyaert KAM, van der Kallen CJH, et al
    (Pre)diabetes and a higher level of glycaemic measures are continuously associated with corneal neurodegeneration assessed by corneal confocal microscopy: the Maastricht Study.
    Diabetologia. 2023 Aug 17. doi: 10.1007/s00125-023-05986.
    >> Share

  196. OOSTVEEN RF, Kaiser Y, Stahle MR, Nurmohamed NS, et al
    Atorvastatin lowers (68)Ga-DOTATATE uptake in coronary arteries, bone marrow and spleen in individuals with type 2 diabetes.
    Diabetologia. 2023 Aug 15. doi: 10.1007/s00125-023-05990.
    >> Share

  197. ZHAO X, Zhang X, Pei J, Liu Y, et al
    Targeting BCAA metabolism to potentiate metformin's therapeutic efficacy in the treatment of diabetes in mice.
    Diabetologia. 2023 Aug 15. doi: 10.1007/s00125-023-05985.
    >> Share

  198. MATHIEU C, Ahmadzai I
    Incretins beyond type 2 diabetes.
    Diabetologia. 2023 Aug 8. doi: 10.1007/s00125-023-05980.
    >> Share

  199. SOLINI A, Trico D, Del Prato S
    Incretins and cardiovascular disease: to the heart of type 2 diabetes?
    Diabetologia. 2023 Aug 5. doi: 10.1007/s00125-023-05973.
    >> Share

  200. MOULDER R, Valikangas T, Hirvonen MK, Suomi T, et al
    Targeted serum proteomics of longitudinal samples from newly diagnosed youth with type 1 diabetes distinguishes markers of disease and C-peptide trajectory.
    Diabetologia. 2023 Aug 4. doi: 10.1007/s00125-023-05974.
    >> Share

  201. TANG H, Wang J, Deng P, Li Y, et al
    Transcriptome-wide association study-derived genes as potential visceral adipose tissue-specific targets for type 2 diabetes.
    Diabetologia. 2023 Aug 4. doi: 10.1007/s00125-023-05978.
    >> Share

  202. FALKENTOFT AC, Gerds TA, Zareini B, Knop FK, et al
    Risk of first-time major cardiovascular event among individuals with newly diagnosed type 2 diabetes: data from Danish registers.
    Diabetologia. 2023 Aug 2. doi: 10.1007/s00125-023-05977.
    >> Share

  203. WEWER ALBRECHTSEN NJ, Holst JJ, Cherrington AD, Finan B, et al
    100 years of glucagon and 100 more.
    Diabetologia. 2023;66:1378-1394.
    >> Share

  204. YARMOLINSKY J, Bouras E, Constantinescu A, Burrows K, et al
    Genetically proxied glucose-lowering drug target perturbation and risk of cancer: a Mendelian randomisation analysis.
    Diabetologia. 2023;66:1481-1500.
    >> Share

    July 2023
  205. ANSON M, Zhao SS, Austin P, Ibarburu GH, et al
    SGLT2i and GLP-1 RA therapy in type 1 diabetes and reno-vascular outcomes: a real-world study.
    Diabetologia. 2023 Jul 28. doi: 10.1007/s00125-023-05975.
    >> Share

  206. KOSJERINA V, Carstensen B, Amadid H, Vistisen D, et al
    Glycaemic control, risk of hypoglycaemia and all-cause mortality in new users of second-generation basal insulin with type 2 diabetes and chronic kidney disease: a nationwide register-based cohort study.
    Diabetologia. 2023 Jul 28. doi: 10.1007/s00125-023-05971.
    >> Share

  207. KOBAYASHI Y, Long J, Dan S, Johannsen NM, et al
    Strength training is more effective than aerobic exercise for improving glycaemic control and body composition in people with normal-weight type 2 diabetes: a randomised controlled trial.
    Diabetologia. 2023 Jul 26. doi: 10.1007/s00125-023-05958.
    >> Share

  208. THOMPSON PJ, Pipella J, Rutter GA, Gaisano HY, et al
    Islet autoimmunity in human type 1 diabetes: initiation and progression from the perspective of the beta cell.
    Diabetologia. 2023 Jul 25. doi: 10.1007/s00125-023-05970.
    >> Share

  209. RIAHI Y, Kogot-Levin A, Kadosh L, Agranovich B, et al
    Hyperglucagonaemia in diabetes: altered amino acid metabolism triggers mTORC1 activation, which drives glucagon production.
    Diabetologia. 2023 Jul 22. doi: 10.1007/s00125-023-05967.
    >> Share

  210. GARRIB A, Kivuyo S, Bates K, Ramaiya K, et al
    Metformin for the prevention of diabetes among people with HIV and either impaired fasting glucose or impaired glucose tolerance (prediabetes) in Tanzania: a Phase II randomised placebo-controlled trial.
    Diabetologia. 2023 Jul 18. doi: 10.1007/s00125-023-05968.
    >> Share

  211. SHAH R, Spektor TM, Weisenberger DJ, Ding H, et al
    Reversal of dual epigenetic repression of non-canonical Wnt-5a normalises diabetic corneal epithelial wound healing and stem cells.
    Diabetologia. 2023 Jul 18. doi: 10.1007/s00125-023-05960.
    >> Share

  212. LYSSENKO V, Vaag A
    Genetics of diabetes-associated microvascular complications.
    Diabetologia. 2023 Jul 14. doi: 10.1007/s00125-023-05964.
    >> Share

  213. LUCKETT AM, Weedon MN, Hawkes G, Leslie RD, et al
    Utility of genetic risk scores in type 1 diabetes.
    Diabetologia. 2023 Jul 13. doi: 10.1007/s00125-023-05955.
    >> Share

  214. MEEK CL
    An unwelcome inheritance: childhood obesity after diabetes in pregnancy.
    Diabetologia. 2023 Jul 13. doi: 10.1007/s00125-023-05965.
    >> Share

  215. NAUCK MA, Muller TD
    Incretin hormones and type 2 diabetes.
    Diabetologia. 2023 Jul 11. doi: 10.1007/s00125-023-05956.
    >> Share

  216. LI JH, Brenner LN, Kaur V, Figueroa K, et al
    Genome-wide association analysis identifies ancestry-specific genetic variation associated with acute response to metformin and glipizide in SUGAR-MGH.
    Diabetologia. 2023;66:1260-1272.
    >> Share

  217. YANG W, Liao W, Li X, Ai W, et al
    Hepatic p38alpha MAPK controls gluconeogenesis via FOXO1 phosphorylation at S273 during glucagon signalling in mice.
    Diabetologia. 2023;66:1322-1339.
    >> Share

  218. GORGOGIETAS V, Rajaei B, Heeyoung C, Santacreu BJ, et al
    GLP-1R agonists demonstrate potential to treat Wolfram syndrome in human preclinical models.
    Diabetologia. 2023;66:1306-1321.
    >> Share

  219. DE RITTER R, Stehouwer CDA
    Further investigation of the association between diabetes status and body composition and whether this association is moderated by sex. Reply to Mai Y [letter].
    Diabetologia. 2023 Jul 1. doi: 10.1007/s00125-023-05959.
    >> Share

    June 2023
  220. FAN M, Stephan AJ, Emmert-Fees K, Peters A, et al
    Health and economic impact of improved glucose, blood pressure and lipid control among German adults with type 2 diabetes: a modelling study.
    Diabetologia. 2023 Jun 30. doi: 10.1007/s00125-023-05950.
    >> Share

  221. LITTLE K, Singh A, Del Marco A, Llorian-Salvador M, et al
    Disruption of cortical cell type composition and function underlies diabetes-associated cognitive decline.
    Diabetologia. 2023 Jun 23. doi: 10.1007/s00125-023-05935.
    >> Share

  222. KUSS O, Opitz ME, Brandstetter LV, Schlesinger S, et al
    How amenable is type 2 diabetes treatment for precision diabetology? A meta-regression of glycaemic control data from 174 randomised trials.
    Diabetologia. 2023 Jun 20. doi: 10.1007/s00125-023-05951.
    >> Share

  223. HUMMEL S, Carl J, Friedl N, Winkler C, et al
    Children diagnosed with presymptomatic type 1 diabetes through public health screening have milder diabetes at clinical manifestation.
    Diabetologia. 2023 Jun 17. doi: 10.1007/s00125-023-05953.
    >> Share

  224. MAI Y
    Further investigation of the association between diabetes status and body composition and whether this association is moderated by sex.
    Diabetologia. 2023 Jun 15. doi: 10.1007/s00125-023-05919.
    >> Share

  225. HAMMER SS, Dorweiler TF, McFarland D, Adu-Agyeiwaah Y, et al
    Cholesterol crystal formation is a unifying pathogenic mechanism in the development of diabetic retinopathy.
    Diabetologia. 2023 Jun 14. doi: 10.1007/s00125-023-05949.
    >> Share

  226. PIEBER TR, Arfelt KN, Cailleteau R, Hart M, et al
    Hypoglycaemia frequency and physiological response after double or triple doses of once-weekly insulin icodec vs once-daily insulin glargine U100 in type 2 diabetes: a randomised crossover trial.
    Diabetologia. 2023 Jun 13. doi: 10.1007/s00125-023-05921.
    >> Share

  227. LUO H, Bauer A, Nano J, Petrera A, et al
    Associations of plasma proteomics with type 2 diabetes and related traits: results from the longitudinal KORA S4/F4/FF4 Study.
    Diabetologia. 2023 Jun 13. doi: 10.1007/s00125-023-05943.
    >> Share

  228. WIBAEK R, Andersen GS, Linneberg A, Hansen T, et al
    Low birthweight is associated with a higher incidence of type 2 diabetes over two decades independent of adult BMI and genetic predisposition.
    Diabetologia. 2023 Jun 12. doi: 10.1007/s00125-023-05937.
    >> Share

  229. HANSEN AL, Thomsen RW, Brons C, Svane HML, et al
    Birthweight is associated with clinical characteristics in people with recently diagnosed type 2 diabetes.
    Diabetologia. 2023 Jun 12. doi: 10.1007/s00125-023-05936.
    >> Share

  230. SIERRA-SILVESTRE E, Andrade RJ, Holguin-Colorado L, Edwards K, et al
    Occurrence of corneal sub-epithelial microneuromas and axonal swelling in people with diabetes with and without (painful) diabetic neuropathy.
    Diabetologia. 2023 Jun 10:1-16. doi: 10.1007/s00125-023-05945.
    >> Share

  231. LAMPOUSI AM, Carlsson S, Lofvenborg JE, Cabrera-Castro N, et al
    Interaction between plasma phospholipid odd-chain fatty acids and GAD65 autoantibodies on the incidence of adult-onset diabetes: the EPIC-InterAct case-cohort study.
    Diabetologia. 2023 Jun 10. doi: 10.1007/s00125-023-05948.
    >> Share

  232. TANG R, Zhong T, Lei K, Lin X, et al
    Recovery of intracellular glucose uptake in T cells during partial remission of type 1 diabetes.
    Diabetologia. 2023 Jun 10. doi: 10.1007/s00125-023-05938.
    >> Share

  233. BROSSAUD J, Bosch-Bouju C, Marissal-Arvy N, Campas-Lebecque MN, et al
    Memory deficits in a juvenile rat model of type 1 diabetes are due to excess 11beta-HSD1 activity, which is upregulated by high glucose concentrations rather than insulin deficiency.
    Diabetologia. 2023 Jun 10. doi: 10.1007/s00125-023-05942.
    >> Share

  234. HAWKES G, Beaumont RN, Tyrrell J, Power GM, et al
    Genetic evidence that high BMI in childhood has a protective effect on intermediate diabetes traits, including measures of insulin sensitivity and secretion, after accounting for BMI in adulthood.
    Diabetologia. 2023 Jun 6. doi: 10.1007/s00125-023-05923.
    >> Share

  235. SIMO R, Hernandez C
    What else can we do to prevent diabetic retinopathy?
    Diabetologia. 2023 Jun 6. doi: 10.1007/s00125-023-05940.
    >> Share

  236. YOUNG KG, McGovern AP, Barroso I, Hattersley AT, et al
    HbA(1c) screening for the diagnosis of diabetes. Reply to Broz J, Brabec M, Krollova P et al [letter].
    Diabetologia. 2023 Jun 5. doi: 10.1007/s00125-023-05939.
    >> Share

  237. TURK D, Scherer N, Selzer D, Dings C, et al
    Significant impact of time-of-day variation on metformin pharmacokinetics.
    Diabetologia. 2023;66:1024-1034.
    >> Share

  238. VANDERKRUK B, Maeshima N, Pasula DJ, An M, et al
    Methylation of histone H3 lysine 4 is required for maintenance of beta cell function in adult mice.
    Diabetologia. 2023;66:1097-1115.
    >> Share

  239. BLOND MB, Faerch K, Herder C, Ziegler D, et al
    The prediabetes conundrum: striking the balance between risk and resources.
    Diabetologia. 2023;66:1016-1023.
    >> Share

  240. ANDERSON EL, Williams DM
    Drug target Mendelian randomisation: are we really instrumenting drug use?
    Diabetologia. 2023;66:1156-1158.
    >> Share

    May 2023
  241. ZIEGLER AG
    The countdown to type 1 diabetes: when, how and why does the clock start?
    Diabetologia. 2023 May 26. doi: 10.1007/s00125-023-05927.
    >> Share

  242. TERWEE CB, Elders PJM, Blom MT, Beulens JW, et al
    Patient-reported outcomes for people with diabetes: what and how to measure? A narrative review.
    Diabetologia. 2023 May 24. doi: 10.1007/s00125-023-05926.
    >> Share

  243. CARLSSON PO, Espes D, Sisay S, Davies LC, et al
    Umbilical cord-derived mesenchymal stromal cells preserve endogenous insulin production in type 1 diabetes: a Phase I/II randomised double-blind placebo-controlled trial.
    Diabetologia. 2023 May 24. doi: 10.1007/s00125-023-05934.
    >> Share

  244. HU J, Fang M, Pike JR, Lutsey PL, et al
    Prediabetes, intervening diabetes and subsequent risk of dementia: the Atherosclerosis Risk in Communities (ARIC) study.
    Diabetologia. 2023 May 24. doi: 10.1007/s00125-023-05930.
    >> Share

  245. BROZ J, Brabec M, Krollova P, Fackovcova L, et al
    HbA(1c) screening for the diagnosis of diabetes.
    Diabetologia. 2023 May 23. doi: 10.1007/s00125-023-05924.
    >> Share

  246. YOUNG KG, McGovern AP, Barroso I, Hattersley AT, et al
    Correction to: The impact of population-level HbA(1c) screening on reducing diabetes diagnostic delay in middle-aged adults: a UK Biobank analysis.
    Diabetologia. 2023 May 22. doi: 10.1007/s00125-023-05933.
    >> Share

  247. SCHLESINGER S, Lang A, Christodoulou N, Linnerz P, et al
    Risk phenotypes of diabetes and association with COVID-19 severity and death: an update of a living systematic review and meta-analysis.
    Diabetologia. 2023 May 19. doi: 10.1007/s00125-023-05928.
    >> Share

  248. JUVINAO-QUINTERO DL, Sharp GC, Sanderson ECM, Relton CL, et al
    Investigating causality in the association between DNA methylation and type 2 diabetes using bidirectional two-sample Mendelian randomisation.
    Diabetologia. 2023 May 19. doi: 10.1007/s00125-023-05914.
    >> Share

  249. YANG Z, Wu Y, Xu L, Zhu Z, et al
    Age at diagnosis modifies associations of type 2 diabetes with cancer incidence and mortality: a retrospective matched-cohort study.
    Diabetologia. 2023 May 13. doi: 10.1007/s00125-023-05920.
    >> Share

  250. HUERTA-CHAGOYA A, Schroeder P, Mandla R, Deutsch AJ, et al
    The power of TOPMed imputation for the discovery of Latino-enriched rare variants associated with type 2 diabetes.
    Diabetologia. 2023 May 6. doi: 10.1007/s00125-023-05912.
    >> Share

  251. LUTTER D, Sachs S, Walter M, Kerege A, et al
    Skeletal muscle and intermuscular adipose tissue gene expression profiling identifies new biomarkers with prognostic significance for insulin resistance progression and intervention response.
    Diabetologia. 2023;66:873-883.
    >> Share

  252. LEE DS, An TH, Kim H, Jung E, et al
    Tcf7l2 in hepatocytes regulates de novo lipogenesis in diet-induced non-alcoholic fatty liver disease in mice.
    Diabetologia. 2023;66:931-954.
    >> Share

  253. MARZINOTTO I, Pittman DL, Williams AJK, Long AE, et al
    Islet Autoantibody Standardization Program: interlaboratory comparison of insulin autoantibody assay performance in 2018 and 2020 workshops.
    Diabetologia. 2023;66:897-912.
    >> Share

  254. WENG SW, Wu JC, Shen FC, Chang YH, et al
    Chaperonin counteracts diet-induced non-alcoholic fatty liver disease by aiding sirtuin 3 in the control of fatty acid oxidation.
    Diabetologia. 2023;66:913-930.
    >> Share

    April 2023
  255. ELSENBURG LK, Bengtsson J, Rieckmann A, Rod NH, et al
    Childhood adversity and risk of type 2 diabetes in early adulthood: results from a population-wide cohort study of 1.2 million individuals.
    Diabetologia. 2023 Apr 20. doi: 10.1007/s00125-023-05911.
    >> Share

  256. REYNOLDS A
    Evidence-based European recommendations for the dietary management of diabetes.
    Diabetologia. 2023 Apr 17. doi: 10.1007/s00125-023-05894.
    >> Share

  257. KAUTZKY-WILLER A, Leutner M, Harreiter J
    Correction to: Sex differences in type 2 diabetes.
    Diabetologia. 2023 Apr 12. doi: 10.1007/s00125-023-05913.
    >> Share

  258. LAUGESEN C, Ranjan AG, Schmidt S, Norgaard K, et al
    Pen-administered low-dose dasiglucagon vs usual care for prevention and treatment of non-severe hypoglycaemia in people with type 1 diabetes during free-living conditions: a Phase II, randomised, open-label, two-period crossover trial.
    Diabetologia. 2023 Apr 11. doi: 10.1007/s00125-023-05909.
    >> Share

  259. MCNEILLY AD, Gallagher JR, Evans ML, de Galan BE, et al
    Chronic hyperglycaemia increases the vulnerability of the hippocampus to oxidative damage induced during post-hypoglycaemic hyperglycaemia in a mouse model of chemically induced type 1 diabetes.
    Diabetologia. 2023 Apr 4. doi: 10.1007/s00125-023-05907.
    >> Share

  260. HELLEPUTTE S, Yardley JE, Scott SN, Stautemas J, et al
    Effects of postprandial exercise on blood glucose levels in adults with type 1 diabetes: a review.
    Diabetologia. 2023 Apr 4. doi: 10.1007/s00125-023-05910.
    >> Share

  261. MATTIS KK, Krentz NAJ, Metzendorf C, Abaitua F, et al
    Loss of RREB1 in pancreatic beta cells reduces cellular insulin content and affects endocrine cell gene expression.
    Diabetologia. 2023;66:674-694.
    >> Share

  262. SEPULVEDA E, Jacob P, Poinhos R, Carvalho D, et al
    Changes in attitudes to awareness of hypoglycaemia during a hypoglycaemia awareness restoration programme are associated with avoidance of further severe hypoglycaemia episodes within 24 months: the A2A in HypoCOMPaSS study.
    Diabetologia. 2023;66:631-641.
    >> Share

  263. RADLINGER B, Ress C, Folie S, Salzmann K, et al
    Empagliflozin protects mice against diet-induced obesity, insulin resistance and hepatic steatosis.
    Diabetologia. 2023;66:754-767.
    >> Share

  264. TARIQ M, de Souza AH, Bensellam M, Chae H, et al
    Prolonged culture of human pancreatic islets under glucotoxic conditions changes their acute beta cell calcium and insulin secretion glucose response curves from sigmoid to bell-shaped.
    Diabetologia. 2023;66:709-723.
    >> Share

    March 2023
  265. ROCA-RIVADA A, Marin-Canas S, Colli ML, Vinci C, et al
    Inhibition of the type 1 diabetes candidate gene PTPN2 aggravates TNF-alpha-induced human beta cell dysfunction and death.
    Diabetologia. 2023 Mar 29. doi: 10.1007/s00125-023-05908.
    >> Share

  266. BELTEKY M, Milletich PL, Ahrens AP, Triplett EW, et al
    Infant gut microbiome composition correlated with type 1 diabetes acquisition in the general population: the ABIS study.
    Diabetologia. 2023 Mar 25. doi: 10.1007/s00125-023-05895.
    >> Share

  267. RATTER-RIECK JM, Roden M, Herder C
    Diabetes and climate change: current evidence and implications for people with diabetes, clinicians and policy stakeholders.
    Diabetologia. 2023 Mar 25:1-13. doi: 10.1007/s00125-023-05901.
    >> Share

  268. HENEBERG P
    A large portion of diabetes cases in sub-Saharan African populations with HIV represent drug-induced diabetes.
    Diabetologia. 2023 Mar 23. doi: 10.1007/s00125-023-05904.
    >> Share

  269. HATANO Y, VanWagner LB, Carnethon MR, Bancks MP, et al
    Racial difference in the association between non-alcoholic fatty liver disease and incident type 2 diabetes: findings from the CARDIA study.
    Diabetologia. 2023 Mar 21. doi: 10.1007/s00125-023-05903.
    >> Share

  270. LLOYD M, Morton J, Teede H, Marquina C, et al
    Long-term cost-effectiveness of implementing a lifestyle intervention during pregnancy to reduce the incidence of gestational diabetes and type 2 diabetes.
    Diabetologia. 2023 Mar 18. doi: 10.1007/s00125-023-05897.
    >> Share

  271. LI X, Yang Y, Li Z, Wang Y, et al
    Deficiency of WTAP in islet beta cells results in beta cell failure and diabetes in mice.
    Diabetologia. 2023 Mar 15. doi: 10.1007/s00125-023-05900.
    >> Share

  272. REYNOLDS EL, Watanabe M, Banerjee M, Chant E, et al
    The effect of surgical weight loss on diabetes complications in individuals with class II/III obesity.
    Diabetologia. 2023 Mar 14:1-16. doi: 10.1007/s00125-023-05899.
    >> Share

  273. XIAO Y, Wang Y, Ryu J, Liu W, et al
    Upregulated TGF-beta1 contributes to hyperglycaemia in type 2 diabetes by potentiating glucagon signalling.
    Diabetologia. 2023 Mar 14. doi: 10.1007/s00125-023-05889.
    >> Share

  274. RUDMAN N, Kaur S, Simunovic V, Kifer D, et al
    Integrated glycomics and genetics analyses reveal a potential role for N-glycosylation of plasma proteins and IgGs, as well as the complement system, in the development of type 1 diabetes.
    Diabetologia. 2023 Mar 13. doi: 10.1007/s00125-023-05881.
    >> Share

  275. KAUTZKY-WILLER A, Leutner M, Harreiter J
    Sex differences in type 2 diabetes.
    Diabetologia. 2023 Mar 10. doi: 10.1007/s00125-023-05891.
    >> Share

  276. APAOLAZA PS, Balcacean D, Zapardiel-Gonzalo J, Rodriguez-Calvo T, et al
    The extent and magnitude of islet T cell infiltration as powerful tools to define the progression to type 1 diabetes.
    Diabetologia. 2023 Mar 8. doi: 10.1007/s00125-023-05888.
    >> Share

  277. DRENTHEN LCA, Ajie M, Abbink EJ, Rodwell L, et al
    No insulin degludec dose adjustment required after aerobic exercise for people with type 1 diabetes: the ADREM study.
    Diabetologia. 2023 Mar 7:1-10. doi: 10.1007/s00125-023-05893.
    >> Share

  278. WEDEKIND LE, Mahajan A, Hsueh WC, Chen P, et al
    The utility of a type 2 diabetes polygenic score in addition to clinical variables for prediction of type 2 diabetes incidence in birth, youth and adult cohorts in an Indigenous study population.
    Diabetologia. 2023 Mar 2. doi: 10.1007/s00125-023-05870.
    >> Share

  279. MATHIEU C, Kennedy E, Schrauwen P, Mulder H, et al
    The changing landscape of scientific communication at EASD.
    Diabetologia. 2023;66:413-414.
    >> Share

  280. DU L, Wang P, Chen H, Zhang Y, et al
    GLP1RAs vs SGLT2is were associated with lower risk of major adverse limb events and similar risks of heart failure hospitalisation and stroke?
    Diabetologia. 2023;66:605-606.
    >> Share

  281. ARSHI B, Chen J, Ikram MA, Zillikens MC, et al
    Advanced glycation end-products, cardiac function and heart failure in the general population: The Rotterdam Study.
    Diabetologia. 2023;66:472-481.
    >> Share

  282. VAN DER VELDE JHPM, Boone SC, Winters-van Eekelen E, Hesselink MKC, et al
    Timing of physical activity in relation to liver fat content and insulin resistance.
    Diabetologia. 2023;66:461-471.
    >> Share

  283. PIGEYRE M, Gerstein H, Ahlqvist E, Hess S, et al
    Identifying blood biomarkers for type 2 diabetes subtyping: a report from the ORIGIN trial.
    Diabetologia. 2023 Mar 1. doi: 10.1007/s00125-023-05887.
    >> Share

    February 2023
  284. WEI Y, Richardson TG, Zhan Y, Carlsson S, et al
    Childhood adiposity and novel subtypes of adult-onset diabetes: a Mendelian randomisation and genome-wide genetic correlation study.
    Diabetologia. 2023 Feb 27. doi: 10.1007/s00125-023-05883.
    >> Share

  285. DE KLERK JA, Beulens JWJ, Mei H, Bijkerk R, et al
    Altered blood gene expression in the obesity-related type 2 diabetes cluster may be causally involved in lipid metabolism: a Mendelian randomisation study.
    Diabetologia. 2023 Feb 24. doi: 10.1007/s00125-023-05886.
    >> Share

  286. DE RITTER R, Sep SJS, van Greevenbroek MMJ, Kusters YHAM, et al
    Sex differences in body composition in people with prediabetes and type 2 diabetes as compared with people with normal glucose metabolism: the Maastricht Study.
    Diabetologia. 2023 Feb 20. doi: 10.1007/s00125-023-05880.
    >> Share

  287. YUAN S, Merino J, Larsson SC
    Causal factors underlying diabetes risk informed by Mendelian randomisation analysis: evidence, opportunities and challenges.
    Diabetologia. 2023 Feb 14. doi: 10.1007/s00125-023-05879.
    >> Share

  288. FOROUHI NG
    Embracing complexity: making sense of diet, nutrition, obesity and type 2 diabetes.
    Diabetologia. 2023 Feb 14:1-14. doi: 10.1007/s00125-023-05873.
    >> Share

  289. GULLAKSEN S, Vernstrom L, Sorensen SS, Ringgaard S, et al
    Separate and combined effects of semaglutide and empagliflozin on kidney oxygenation and perfusion in people with type 2 diabetes: a randomised trial.
    Diabetologia. 2023 Feb 6. doi: 10.1007/s00125-023-05876.
    >> Share

  290. MUTIE PM, Pomares-Milan H, Atabaki-Pasdar N, Coral D, et al
    Investigating the causal relationships between excess adiposity and cardiometabolic health in men and women.
    Diabetologia. 2023;66:321-335.
    >> Share

    January 2023
  291. LAFERRERE B
    Determination of autoantibodies in type 2 diabetes: one simple way to improve classification. Reply by Laferrere to Ludvigsson J [letter].
    Diabetologia. 2023 Jan 31. doi: 10.1007/s00125-023-05871.
    >> Share

  292. DE VRIES SAG, Verheugt CL, Mul D, Nieuwdorp M, et al
    Do sex differences in paediatric type 1 diabetes care exist? A systematic review.
    Diabetologia. 2023 Jan 26. doi: 10.1007/s00125-022-05866.
    >> Share

  293. SAADANE A, Veenstra AA, Minns MS, Tang J, et al
    CCR2-positive monocytes contribute to the pathogenesis of early diabetic retinopathy in mice.
    Diabetologia. 2023 Jan 26. doi: 10.1007/s00125-022-05860.
    >> Share

  294. CARRERA P, Marzinotto I, Bonfanti R, Massimino L, et al
    Genetic determinants of type 1 diabetes in individuals with weak evidence of islet autoimmunity at disease onset.
    Diabetologia. 2023 Jan 24. doi: 10.1007/s00125-022-05865.
    >> Share

  295. GOEDECKE JH, Pheiffer C, Mendham AE
    Environmental exposures are important for type 2 diabetes pathophysiology in sub-Saharan African populations. Reply to Christensen D, Hjort L, Mpagama S et al [letter].
    Diabetologia. 2023 Jan 24. doi: 10.1007/s00125-022-05859.
    >> Share

  296. LEAN MEJ, Taylor R, Sattar N
    Determination of autoantibodies in type 2 diabetes: one simple way to improve classification. Reply by Lean et al to Ludvigsson J [letter].
    Diabetologia. 2023 Jan 24:1-2. doi: 10.1007/s00125-022-05863.
    >> Share

  297. LING S, Zaccardi F, Issa E, Davies MJ, et al
    Inequalities in cancer mortality trends in people with type 2 diabetes: 20 year population-based study in England.
    Diabetologia. 2023 Jan 24. doi: 10.1007/s00125-022-05854.
    >> Share

  298. CHRISTENSEN DL, Hjort L, Mpagama SG, Ramaiya KL, et al
    Environmental exposures are important for type 2 diabetes pathophysiology in sub-Saharan African populations.
    Diabetologia. 2023 Jan 19. doi: 10.1007/s00125-022-05867.
    >> Share

  299. HARE MJL, Maple-Brown LJ, Shaw JE, Boyle JA, et al
    Risk of kidney disease following a pregnancy complicated by diabetes: a longitudinal, population-based data-linkage study among Aboriginal women in the Northern Territory, Australia.
    Diabetologia. 2023 Jan 18. doi: 10.1007/s00125-023-05868.
    >> Share

  300. ROSENGREN A, Dikaiou P
    Cardiovascular outcomes in type 1 and type 2 diabetes.
    Diabetologia. 2023 Jan 14:1-13. doi: 10.1007/s00125-022-05857.
    >> Share

  301. THORIUS IH, Husemoen LLN, Nordsborg RB, Alibegovic AC, et al
    Congenital malformations among offspring of women with type 1 diabetes who use insulin pumps: a prospective cohort study.
    Diabetologia. 2023 Jan 14. doi: 10.1007/s00125-022-05864.
    >> Share

  302. LAFONTAINE N, Jolley J, Kyi M, King S, et al
    Prospective randomised placebo-controlled trial assessing the efficacy of silver dressings to enhance healing of acute diabetes-related foot ulcers.
    Diabetologia. 2023 Jan 11. doi: 10.1007/s00125-022-05855.
    >> Share

  303. LUDVIGSSON J
    Determination of autoantibodies in type 2 diabetes: one simple way to improve classification.
    Diabetologia. 2023 Jan 11. doi: 10.1007/s00125-022-05858.
    >> Share

  304. LUPSA BC, Kibbey RG, Inzucchi SE
    Ketones: the double-edged sword of SGLT2 inhibitors?
    Diabetologia. 2023;66:23-32.
    >> Share

  305. ILIODROMITI S, McLaren J, Ghouri N, Miller MR, et al
    Liver, visceral and subcutaneous fat in men and women of South Asian and white European descent: a systematic review and meta-analysis of new and published data.
    Diabetologia. 2023;66:44-56.
    >> Share

  306. MENDHAM AE, Micklesfield LK, Karpe F, Kengne AP, et al
    Targeted proteomics identifies potential biomarkers of dysglycaemia, beta cell function and insulin sensitivity in Black African men and women.
    Diabetologia. 2023;66:174-189.
    >> Share

    December 2022
  307. PENZENSTADLER J, Earp JC, Wood Heickman LK, Pluchino K, et al
    Utility of islet autoantibodies as enrichment biomarkers in type 1 diabetes clinical studies: a viewpoint from the FDA.
    Diabetologia. 2022 Dec 21. doi: 10.1007/s00125-022-05853.
    >> Share

  308. KIM H, Westerman KE, Smith K, Chiou J, et al
    High-throughput genetic clustering of type 2 diabetes loci reveals heterogeneous mechanistic pathways of metabolic disease.
    Diabetologia. 2022 Dec 20. doi: 10.1007/s00125-022-05848.
    >> Share

  309. LAZZARINI PA, Cramb SM, Golledge J, Morton JI, et al
    Global trends in the incidence of hospital admissions for diabetes-related foot disease and amputations: a review of national rates in the 21st century.
    Diabetologia. 2022 Dec 13. doi: 10.1007/s00125-022-05845.
    >> Share

  310. BOLDISON J, Hopkinson JR, Davies J, Pearson JA, et al
    Gene expression profiling in NOD mice reveals that B cells are highly educated by the pancreatic environment during autoimmune diabetes.
    Diabetologia. 2022 Dec 12. doi: 10.1007/s00125-022-05839.
    >> Share

  311. MAALMI H, Strom A, Petrera A, Hauck SM, et al
    Serum neurofilament light chain: a novel biomarker for early diabetic sensorimotor polyneuropathy.
    Diabetologia. 2022 Dec 6. doi: 10.1007/s00125-022-05846.
    >> Share

  312. FERRANNINI E, Mari A, Monaco GSF, Skyler JS, et al
    The effect of age on longitudinal measures of beta cell function and insulin sensitivity during the progression of early stage type 1 diabetes.
    Diabetologia. 2022 Dec 2. doi: 10.1007/s00125-022-05836.
    >> Share

  313. SCHOONEJANS JM, Blackmore HL, Ashmore TJ, Pantaleao LC, et al
    Sex-specific effects of maternal metformin intervention during glucose-intolerant obese pregnancy on body composition and metabolic health in aged mouse offspring.
    Diabetologia. 2022;65:2132-2145.
    >> Share

  314. MASSARA P, Zurbau A, Glenn AJ, Chiavaroli L, et al
    Nordic dietary patterns and cardiometabolic outcomes: a systematic review and meta-analysis of prospective cohort studies and randomised controlled trials.
    Diabetologia. 2022;65:2011-2031.
    >> Share

    November 2022
  315. MISTRY S, Gouripeddi R, Raman V, Facelli JC, et al
    Stratifying risk for onset of type 1 diabetes using islet autoantibody trajectory clustering.
    Diabetologia. 2022 Nov 30. doi: 10.1007/s00125-022-05843.
    >> Share

  316. MATHIEU C, Del Prato S
    Women in diabetes research: we can do better. Reply to Bonnefond A [letter].
    Diabetologia. 2022 Nov 29. doi: 10.1007/s00125-022-05840.
    >> Share

  317. BONNEFOND A
    Women in diabetes research: we can do better.
    Diabetologia. 2022 Nov 26. doi: 10.1007/s00125-022-05825.
    >> Share

  318. KHUNTI K, Valabhji J, Misra S
    Diabetes and the COVID-19 pandemic.
    Diabetologia. 2022 Nov 23. doi: 10.1007/s00125-022-05833.
    >> Share

  319. HARSUNEN M, Kettunen JLT, Harkonen T, Dwivedi O, et al
    Identification of monogenic variants in more than ten per cent of children without type 1 diabetes-related autoantibodies at diagnosis in the Finnish Pediatric Diabetes Register.
    Diabetologia. 2022 Nov 23. doi: 10.1007/s00125-022-05834.
    >> Share

  320. YOUNG KG, McGovern AP, Barroso I, Hattersley AT, et al
    The impact of population-level HbA(1c) screening on reducing diabetes diagnostic delay in middle-aged adults: a UK Biobank analysis.
    Diabetologia. 2022 Nov 22. doi: 10.1007/s00125-022-05824.
    >> Share

  321. HVID H, Brand CL, Hummelshoj T, Jensen S, et al
    Preclinical exploration of combined glucagon inhibition and liver-preferential insulin for treatment of diabetes using in vitro assays and rat and mouse models.
    Diabetologia. 2022 Nov 21. doi: 10.1007/s00125-022-05828.
    >> Share

  322. MORTON JI, Marquina C, Shaw JE, Liew D, et al
    Projecting the incidence and costs of major cardiovascular and kidney complications of type 2 diabetes with widespread SGLT2i and GLP-1 RA use: a cost-effectiveness analysis.
    Diabetologia. 2022 Nov 21. doi: 10.1007/s00125-022-05832.
    >> Share

  323. COOMANS DE BRACHENE A, Scoubeau C, Musuaya AE, Costa-Junior JM, et al
    Exercise as a non-pharmacological intervention to protect pancreatic beta cells in individuals with type 1 and type 2 diabetes.
    Diabetologia. 2022 Nov 19:1-11. doi: 10.1007/s00125-022-05837.
    >> Share

  324. MATHIEU C, Soderberg J, Del Prato S, Felton AM, et al
    The European Diabetes Forum (EUDF): a forum for turning the tide on diabetes in Europe.
    Diabetologia. 2022 Nov 17. pii: 10.1007/s00125-022-05831.
    >> Share

  325. JANSEN TJP, Brom M, Boss M, Buitinga M, et al
    Importance of beta cell mass for glycaemic control in people with type 1 diabetes.
    Diabetologia. 2022 Nov 17. pii: 10.1007/s00125-022-05830.
    >> Share

  326. ZHENG R, Xin Z, Li M, Wang T, et al
    Outdoor light at night in relation to glucose homoeostasis and diabetes in Chinese adults: a national and cross-sectional study of 98,658 participants from 162 study sites.
    Diabetologia. 2022 Nov 14. pii: 10.1007/s00125-022-05819.
    >> Share

  327. THOMAS NJ, Walkey HC, Kaur A, Misra S, et al
    The relationship between islet autoantibody status and the genetic risk of type 1 diabetes in adult-onset type 1 diabetes.
    Diabetologia. 2022 Nov 10. pii: 10.1007/s00125-022-05823.
    >> Share

  328. DAL CANTO E, Elders PJM, van der Heijden AA, van Ballegooijen AJ, et al
    Kidney function measures and cardiovascular outcomes in people with diabetes: the Hoorn Diabetes Care System cohort.
    Diabetologia. 2022 Nov 8. pii: 10.1007/s00125-022-05826.
    >> Share

  329. CUI X, Feng J, Wei T, Zhang L, et al
    Pancreatic alpha cell glucagon-liver FGF21 axis regulates beta cell regeneration in a mouse model of type 2 diabetes.
    Diabetologia. 2022 Nov 4. pii: 10.1007/s00125-022-05822.
    >> Share

  330. BONNER C, Saponaro C
    Where to for precision treatment of HNF1A-MODY?
    Diabetologia. 2022;65:1825-1829.
    >> Share

  331. SPARKS JR, Ghildayal N, Hivert MF, Redman LM, et al
    Lifestyle interventions in pregnancy targeting GDM prevention: looking ahead to precision medicine.
    Diabetologia. 2022;65:1814-1824.
    >> Share

    October 2022
  332. DESOYE G, Ringholm L, Damm P, Mathiesen ER, et al
    Secular trend for increasing birthweight in offspring of pregnant women with type 1 diabetes: is improved placentation the reason?
    Diabetologia. 2022 Oct 26. pii: 10.1007/s00125-022-05820.
    >> Share

  333. REDONDO MJ, Richardson SJ, Perry D, Minard CG, et al
    Milder loss of insulin-containing islets in individuals with type 1 diabetes and type 2 diabetes-associated TCF7L2 genetic variants.
    Diabetologia. 2022 Oct 25. pii: 10.1007/s00125-022-05818.
    >> Share

  334. BRUSCO N, Sebastiani G, Di Giuseppe G, Licata G, et al
    Intra-islet insulin synthesis defects are associated with endoplasmic reticulum stress and loss of beta cell identity in human diabetes.
    Diabetologia. 2022 Oct 25. pii: 10.1007/s00125-022-05814.
    >> Share

  335. ZHU H, Leung SW
    MicroRNA biomarkers of type 2 diabetes: evidence synthesis from meta-analyses and pathway modelling.
    Diabetologia. 2022 Oct 21. pii: 10.1007/s00125-022-05809.
    >> Share

  336. WAERNBAUM I, Lind T, Mollsten A, Dahlquist G, et al
    The incidence of childhood-onset type 1 diabetes, time trends and association with the population composition in Sweden: a 40 year follow-up.
    Diabetologia. 2022 Oct 20. pii: 10.1007/s00125-022-05816.
    >> Share

  337. ZHAO XP, Chang SY, Pang Y, Liao MC, et al
    Hedgehog interacting protein activates sodium-glucose cotransporter 2 expression and promotes renal tubular epithelial cell senescence in a mouse model of type 1 diabetes.
    Diabetologia. 2022 Oct 19. pii: 10.1007/s00125-022-05810.
    >> Share

  338. LO DF, Zia H, Zia T, Visaria A, et al
    Investigating mortality in the association between depression and diabetes.
    Diabetologia. 2022 Oct 12. pii: 10.1007/s00125-022-05807.
    >> Share

  339. STALBOW LA, Preuss MH, Smit RAJ, Chami N, et al
    The contribution of functional HNF1A variants and polygenic susceptibility to risk of type 2 diabetes in ancestrally diverse populations.
    Diabetologia. 2022 Oct 11. pii: 10.1007/s00125-022-05806.
    >> Share

  340. STROLLO R, Vinci C, Man YKS, Bruzzaniti S, et al
    Autoantibody and T cell responses to oxidative post-translationally modified insulin neoantigenic peptides in type 1 diabetes.
    Diabetologia. 2022 Oct 7. pii: 10.1007/s00125-022-05812.
    >> Share

  341. HERING BJ, Ballou CM, Bellin MD, Payne EH, et al
    Factors associated with favourable 5 year outcomes in islet transplant alone recipients with type 1 diabetes complicated by severe hypoglycaemia in the Collaborative Islet Transplant Registry.
    Diabetologia. 2022 Oct 6. pii: 10.1007/s00125-022-05804.
    >> Share

  342. SHERR JL, Heinemann L, Fleming GA, Bergenstal RM, et al
    Automated insulin delivery: benefits, challenges, and recommendations. A Consensus Report of the Joint Diabetes Technology Working Group of the European Association for the Study of Diabetes and the American Diabetes Association.
    Diabetologia. 2022 Oct 6. pii: 10.1007/s00125-022-05744.
    >> Share

  343. ZHANG YB, Pan XF, Lu Q, Wang YX, et al
    Correction to: Associations of combined healthy lifestyles with cancer morbidity and mortality among individuals with diabetes: results from five cohort studies in the USA, the UK and China.
    Diabetologia. 2022 Oct 5. pii: 10.1007/s00125-022-05802.
    >> Share

  344. NG K, Anand V, Stavropoulos H, Veijola R, et al
    Quantifying the utility of islet autoantibody levels in the prediction of type 1 diabetes in children.
    Diabetologia. 2022 Oct 5. pii: 10.1007/s00125-022-05799.
    >> Share

  345. WEISS A, Zapardiel-Gonzalo J, Voss F, Jolink M, et al
    Correction to: Progression likelihood score identifies substages of presymptomatic type 1 diabetes in childhood public health screening.
    Diabetologia. 2022 Oct 4. pii: 10.1007/s00125-022-05798.
    >> Share

  346. JALLEH RJ, Jones KL, Rayner CK, Marathe CS, et al
    Normal and disordered gastric emptying in diabetes: recent insights into (patho)physiology, management and impact on glycaemic control.
    Diabetologia. 2022 Oct 4. pii: 10.1007/s00125-022-05796.
    >> Share

  347. STEFFEN BT, Tang W, Lutsey PL, Demmer RT, et al
    Proteomic analysis of diabetes genetic risk scores identifies complement C2 and neuropilin-2 as predictors of type 2 diabetes: the Atherosclerosis Risk in Communities (ARIC) Study.
    Diabetologia. 2022 Oct 4. pii: 10.1007/s00125-022-05801.
    >> Share

  348. CASTILLO JJ, Aplin AC, Hackney DJ, Hogan MF, et al
    Islet amyloid polypeptide aggregation exerts cytotoxic and proinflammatory effects on the islet vasculature in mice.
    Diabetologia. 2022;65:1687-1700.
    >> Share

    September 2022
  349. SARABHAI T, Mastrototaro L, Kahl S, Bonhof GJ, et al
    Hyperbaric oxygen rapidly improves tissue-specific insulin sensitivity and mitochondrial capacity in humans with type 2 diabetes: a randomised placebo-controlled crossover trial.
    Diabetologia. 2022 Sep 30. pii: 10.1007/s00125-022-05797.
    >> Share

  350. HENRIKSEN RE, Nilsen RM, Strandberg RB
    Loneliness increases the risk of type 2 diabetes: a 20 year follow-up - results from the HUNT study.
    Diabetologia. 2022 Sep 28. pii: 10.1007/s00125-022-05791.
    >> Share

  351. GOEDECKE JH, Mendham AE
    Pathophysiology of type 2 diabetes in sub-Saharan Africans.
    Diabetologia. 2022 Sep 27. pii: 10.1007/s00125-022-05795.
    >> Share

  352. DAVIES MJ, Aroda VR, Collins BS, Gabbay RA, et al
    Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).
    Diabetologia. 2022 Sep 24. pii: 10.1007/s00125-022-05787.
    >> Share

  353. SIMONS PIHG, Valkenburg O, van de Waarenburg MPH, van Greevenbroek MMJ, et al
    Serum sex hormone-binding globulin is a mediator of the association between intrahepatic lipid content and type 2 diabetes: the Maastricht Study.
    Diabetologia. 2022 Sep 17. pii: 10.1007/s00125-022-05790.
    >> Share

  354. ZHANG YB, Pan XF, Lu Q, Wang YX, et al
    Associations of combined healthy lifestyles with cancer morbidity and mortality among individuals with diabetes: results from five cohort studies in the USA, the UK and China.
    Diabetologia. 2022 Sep 14. pii: 10.1007/s00125-022-05754.
    >> Share

  355. KOBO O, Van Spall HGC, Mamas MA
    Urban-rural disparities in diabetes-related mortality in the USA 1999-2019.
    Diabetologia. 2022 Sep 10. pii: 10.1007/s00125-022-05785.
    >> Share

  356. KORDONOURI O, Cuthbertson D, Belteky M, Aschemeier-Fuchs B, et al
    Infections in the first year of life and development of beta cell autoimmunity and clinical type 1 diabetes in high-risk individuals: the TRIGR cohort.
    Diabetologia. 2022 Sep 9. pii: 10.1007/s00125-022-05786.
    >> Share

  357. WANG J, Liu JJ, Gurung RL, Liu S, et al
    Correction: Clinical variable-based cluster analysis identifies novel subgroups with a distinct genetic signature, lipidomic pattern and cardio-renal risks in Asian patients with recent-onset type 2 diabetes.
    Diabetologia. 2022 Sep 7. pii: 10.1007/s00125-022-05783.
    >> Share

  358. DIBATO J, Montvida O, Ling J, Koye D, et al
    Temporal trends in the prevalence and incidence of depression and the interplay of comorbidities in patients with young- and usual-onset type 2 diabetes from the USA and the UK.
    Diabetologia. 2022 Sep 5. pii: 10.1007/s00125-022-05764.
    >> Share

  359. PAPAIOANNOU TG, Sanoudou D, Tsioufis C
    Continuous glucose monitoring and hypoglycaemia events: unmet needs.
    Diabetologia. 2022;65:1569-1570.
    >> Share

    August 2022
  360. WEISS A, Zapardiel-Gonzalo J, Voss F, Jolink M, et al
    Progression likelihood score identifies substages of presymptomatic type 1 diabetes in childhood public health screening.
    Diabetologia. 2022 Aug 27. pii: 10.1007/s00125-022-05780.
    >> Share

  361. GRIFFIN S
    Diabetes precision medicine: plenty of potential, pitfalls and perils but not yet ready for prime time.
    Diabetologia. 2022 Aug 24. pii: 10.1007/s00125-022-05782.
    >> Share

  362. KROOK A, Mulder H
    Pinpointing precision medicine for diabetes mellitus.
    Diabetologia. 2022 Aug 23. pii: 10.1007/s00125-022-05777.
    >> Share

  363. CARR ALJ, Evans-Molina C, Oram RA
    Precision medicine in type 1 diabetes.
    Diabetologia. 2022 Aug 22. pii: 10.1007/s00125-022-05778.
    >> Share

  364. YARDLEY JE
    Reassessing the evidence: prandial state dictates glycaemic responses to exercise in individuals with type 1 diabetes to a greater extent than intensity.
    Diabetologia. 2022 Aug 18. pii: 10.1007/s00125-022-05781.
    >> Share

  365. KROGVOLD L, Genoni A, Puggioni A, Campani D, et al
    Live enteroviruses, but not other viruses, detected in human pancreas at the onset of type 1 diabetes in the DiViD study.
    Diabetologia. 2022 Aug 12. pii: 10.1007/s00125-022-05779.
    >> Share

  366. DEUTSCH AJ, Ahlqvist E, Udler MS
    Phenotypic and genetic classification of diabetes.
    Diabetologia. 2022 Aug 12. pii: 10.1007/s00125-022-05769.
    >> Share

  367. SANCHEZ-SORIANO C, Pearson ER, Reynolds RM
    Associations between parental type 2 diabetes risk and offspring birthweight and placental weight: a survival analysis using the Walker cohort.
    Diabetologia. 2022 Aug 11. pii: 10.1007/s00125-022-05776.
    >> Share

  368. LIN DS, Yu AL, Lo HY, Lien CW, et al
    Major adverse cardiovascular and limb events in people with diabetes treated with GLP-1 receptor agonists vs SGLT2 inhibitors.
    Diabetologia. 2022 Aug 9. pii: 10.1007/s00125-022-05772.
    >> Share

  369. ZHANG X, Ren H, Zhao C, Shi Z, et al
    Metagenomic analysis reveals crosstalk between gut microbiota and glucose-lowering drugs targeting the gastrointestinal tract in Chinese patients with type 2 diabetes: a 6 month, two-arm randomised trial.
    Diabetologia. 2022 Aug 5. pii: 10.1007/s00125-022-05768.
    >> Share

  370. MARILLY E, Cottin J, Cabrera N, Cornu C, et al
    SGLT2 inhibitors in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials balancing their risks and benefits.
    Diabetologia. 2022 Aug 4. pii: 10.1007/s00125-022-05773.
    >> Share

  371. BAO X, Xu B, Muhammad IF, Nilsson PM, et al
    Plasma prostasin: a novel risk marker for incidence of diabetes and cancer mortality.
    Diabetologia. 2022 Aug 4. pii: 10.1007/s00125-022-05771.
    >> Share


  372. 58(th) EASD Annual Meeting of the European Association for the Study of Diabetes : Stockholm, Sweden, 19 - 23 September 2022.
    Diabetologia. 2022 Aug 3. pii: 10.1007/s00125-022-05755.
    >> Share

  373. PORTILLO JC, Yu JS, Vos S, Bapputty R, et al
    Disruption of retinal inflammation and the development of diabetic retinopathy in mice by a CD40-derived peptide or mutation of CD40 in Muller cells.
    Diabetologia. 2022 Aug 3. pii: 10.1007/s00125-022-05775.
    >> Share

  374. WAREHAM NJ
    Personalised prevention of type 2 diabetes.
    Diabetologia. 2022 Aug 2. pii: 10.1007/s00125-022-05774.
    >> Share

  375. MERINO B, Casanueva-Alvarez E, Quesada I, Gonzalez-Casimiro CM, et al
    Insulin-degrading enzyme ablation in mouse pancreatic alpha cells triggers cell proliferation, hyperplasia and glucagon secretion dysregulation.
    Diabetologia. 2022;65:1375-1389.
    >> Share

  376. NGARA M, Wierup N
    Lessons from single-cell RNA sequencing of human islets.
    Diabetologia. 2022;65:1241-1250.
    >> Share

    July 2022
  377. VERGES B
    Intestinal lipid absorption and transport in type 2 diabetes.
    Diabetologia. 2022 Jul 30. pii: 10.1007/s00125-022-05765.
    >> Share

  378. ERIKSSON JW, Eliasson B, Bennet L, Sundstrom J, et al
    Registry-based randomised clinical trials: a remedy for evidence-based diabetes care?
    Diabetologia. 2022 Jul 29. pii: 10.1007/s00125-022-05762.
    >> Share

  379. EDSTORP J, Wei Y, Ahlqvist E, Alfredsson L, et al
    Smoking, use of smokeless tobacco, HLA genotypes and incidence of latent autoimmune diabetes in adults.
    Diabetologia. 2022 Jul 28. pii: 10.1007/s00125-022-05763.
    >> Share

  380. ANDRIESSEN C, Fealy CE, Veelen A, van Beek SMM, et al
    Three weeks of time-restricted eating improves glucose homeostasis in adults with type 2 diabetes but does not improve insulin sensitivity: a randomised crossover trial.
    Diabetologia. 2022 Jul 25. pii: 10.1007/s00125-022-05752.
    >> Share

  381. SIOOFY-KHOJINE AB, Richardson SJ, Locke JM, Oikarinen S, et al
    Detection of enterovirus RNA in peripheral blood mononuclear cells correlates with the presence of the predisposing allele of the type 1 diabetes risk gene IFIH1 and with disease stage.
    Diabetologia. 2022 Jul 22. pii: 10.1007/s00125-022-05753.
    >> Share

  382. KARPEN SR, Dunne JL, Frohnert BI, Marinac M, et al
    Consortium-based approach to receiving an EMA qualification opinion on the use of islet autoantibodies as enrichment biomarkers in type 1 diabetes clinical studies.
    Diabetologia. 2022 Jul 22. pii: 10.1007/s00125-022-05751.
    >> Share

  383. WANG W, Luo J, Willems van Dijk K, Hagg S, et al
    Assessment of the bi-directional relationship between blood mitochondrial DNA copy number and type 2 diabetes mellitus: a multivariable-adjusted regression and Mendelian randomisation study.
    Diabetologia. 2022 Jul 22. pii: 10.1007/s00125-022-05759.
    >> Share

  384. VERHULST CEM, Fabricius TW, Teerenstra S, Kristensen PL, et al
    Glycaemic thresholds for counterregulatory hormone and symptom responses to hypoglycaemia in people with and without type 1 diabetes: a systematic review.
    Diabetologia. 2022 Jul 22. pii: 10.1007/s00125-022-05749.
    >> Share

  385. ZHAO Y, Li Y, Zhuang Z, Song Z, et al
    Associations of polysocial risk score, lifestyle and genetic factors with incident type 2 diabetes: a prospective cohort study.
    Diabetologia. 2022 Jul 21. pii: 10.1007/s00125-022-05761.
    >> Share

  386. LESSIEUR EM, Liu H, Saadane A, Du Y, et al
    ICAM-1 on the luminal surface of endothelial cells is induced to a greater extent in mouse retina than in other tissues in diabetes.
    Diabetologia. 2022 Jul 19. pii: 10.1007/s00125-022-05719.
    >> Share

  387. TAPP RJ, Owen CG, Barman SA, Strachan DP, et al
    Retinal microvascular associations with cardiometabolic risk factors differ by diabetes status: results from the UK Biobank.
    Diabetologia. 2022 Jul 19. pii: 10.1007/s00125-022-05745.
    >> Share

  388. PARK SK, Wang X, Karvonen-Gutierrez CA
    Potential confounders in the association between per- and polyfluoroalkyl substance exposure and diabetes. Reply to Harada KH, Harada Sassa M [letter].
    Diabetologia. 2022 Jul 18. pii: 10.1007/s00125-022-05757.
    >> Share

  389. HARADA KH, Harada Sassa M
    Potential confounders in the association between per- and polyfluoroalkyl substance exposure and diabetes.
    Diabetologia. 2022 Jul 16. pii: 10.1007/s00125-022-05758.
    >> Share

  390. ZOU X, Huang Q, Luo Y, Ren Q, et al
    The efficacy of canagliflozin in diabetes subgroups stratified by data-driven clustering or a supervised machine learning method: a post hoc analysis of canagliflozin clinical trial data.
    Diabetologia. 2022 Jul 8. pii: 10.1007/s00125-022-05748.
    >> Share

  391. HABIBE JJ, Clemente-Olivo MP, Scheithauer TPM, Rampanelli E, et al
    Glucose-mediated insulin secretion is improved in FHL2-deficient mice and elevated FHL2 expression in humans is associated with type 2 diabetes.
    Diabetologia. 2022 Jul 8. pii: 10.1007/s00125-022-05750.
    >> Share

  392. WAIJER SW, Vart P, Cherney DZI, Chertow GM, et al
    Effect of dapagliflozin on kidney and cardiovascular outcomes by baseline KDIGO risk categories: a post hoc analysis of the DAPA-CKD trial.
    Diabetologia. 2022;65:1085-1097.
    >> Share

  393. MEYHOFER S, Dembinski K, Schultes B, Born J, et al
    Sleep deprivation prevents counterregulatory adaptation to recurrent hypoglycaemia.
    Diabetologia. 2022;65:1212-1221.
    >> Share

    June 2022
  394. LIU Q, Tang B, Zhu Z, Kraft P, et al
    A genome-wide cross-trait analysis identifies shared loci and causal relationships of type 2 diabetes and glycaemic traits with polycystic ovary syndrome.
    Diabetologia. 2022 Jun 30. pii: 10.1007/s00125-022-05746.
    >> Share

  395. HUANG X, Qiu Y, Gao Y, Zhou R, et al
    Gut microbiota mediate melatonin signalling in association with type 2 diabetes.
    Diabetologia. 2022 Jun 30. pii: 10.1007/s00125-022-05747.
    >> Share

  396. WANG J, Liu JJ, Gurung RL, Liu S, et al
    Clinical variable-based cluster analysis identifies novel subgroups with a distinct genetic signature, lipidomic pattern and cardio-renal risks in Asian patients with recent-onset type 2 diabetes.
    Diabetologia. 2022 Jun 28. pii: 10.1007/s00125-022-05741.
    >> Share

  397. SANDHOLM N, Cole JB, Nair V, Sheng X, et al
    Genome-wide meta-analysis and omics integration identifies novel genes associated with diabetic kidney disease.
    Diabetologia. 2022 Jun 28. pii: 10.1007/s00125-022-05735.
    >> Share

  398. FLOREZ JC, Pearson ER
    A roadmap to achieve pharmacological precision medicine in diabetes.
    Diabetologia. 2022 Jun 24. pii: 10.1007/s00125-022-05732.
    >> Share

  399. KREMERS SHM, Wild SH, Elders PJM, Beulens JWJ, et al
    The role of mental disorders in precision medicine for diabetes: a narrative review.
    Diabetologia. 2022 Jun 22. pii: 10.1007/s00125-022-05738.
    >> Share

  400. SCHIBORN C, Schulze MB
    Precision prognostics for the development of complications in diabetes.
    Diabetologia. 2022 Jun 21. pii: 10.1007/s00125-022-05731.
    >> Share

  401. WANG H, Gou W, Su C, Du W, et al
    Correction to: Association of gut microbiota with glycaemic traits and incident type 2 diabetes, and modulation by habitual diet: a population-based longitudinal cohort study in Chinese adults.
    Diabetologia. 2022 Jun 20. pii: 10.1007/s00125-022-05737.
    >> Share

  402. LAAJALA E, Kalim UU, Gronroos T, Rasool O, et al
    Umbilical cord blood DNA methylation in children who later develop type 1 diabetes.
    Diabetologia. 2022 Jun 18. pii: 10.1007/s00125-022-05726.
    >> Share

  403. LI G, Zhang J, Van Spall HGC, Douglas PS, et al
    Exploring ethnic representativeness in diabetes clinical trial enrolment from 2000 to 2020: a chronological survey.
    Diabetologia. 2022 Jun 16. pii: 10.1007/s00125-022-05736.
    >> Share

  404. VIGILI DE KREUTZENBERG S, Giannella A, Ceolotto G, Faggin E, et al
    A miR-125/Sirtuin-7 pathway drives the pro-calcific potential of myeloid cells in diabetic vascular disease.
    Diabetologia. 2022 Jun 16. pii: 10.1007/s00125-022-05733.
    >> Share

  405. CARIOU B, Wargny M, Boureau AS, Smati S, et al
    Impact of diabetes on COVID-19 prognosis beyond comorbidity burden: the CORONADO initiative.
    Diabetologia. 2022 Jun 15. pii: 10.1007/s00125-022-05734.
    >> Share

  406. BAILEY J, Coucha M, Bolduc DR, Burnett FN, et al
    GLP-1 receptor nitration contributes to loss of brain pericyte function in a mouse model of diabetes.
    Diabetologia. 2022 Jun 10. pii: 10.1007/s00125-022-05730.
    >> Share

  407. ZUCKER I, Zloof Y, Bardugo A, Tsur AM, et al
    Obesity in late adolescence and incident type 1 diabetes in young adulthood.
    Diabetologia. 2022 Jun 5. pii: 10.1007/s00125-022-05722.
    >> Share

  408. NGUYEN-TU MS, Harris J, Martinez-Sanchez A, Chabosseau P, et al
    Opposing effects on regulated insulin secretion of acute vs chronic stimulation of AMP-activated protein kinase.
    Diabetologia. 2022;65:997-1011.
    >> Share

    May 2022
  409. GRAUSLUND J
    Diabetic retinopathy screening in the emerging era of artificial intelligence.
    Diabetologia. 2022 May 31. pii: 10.1007/s00125-022-05727.
    >> Share

  410. RUDMAN N, Kifer D, Kaur S, Simunovic V, et al
    Children at onset of type 1 diabetes show altered N-glycosylation of plasma proteins and IgG.
    Diabetologia. 2022 May 27. pii: 10.1007/s00125-022-05703.
    >> Share

  411. PRIGGE R, Wild SH, Jackson CA
    Depression, diabetes, comorbid depression and diabetes and risk of all-cause and cause-specific mortality: a prospective cohort study.
    Diabetologia. 2022 May 27. pii: 10.1007/s00125-022-05723.
    >> Share

  412. BONNEFOND A, Semple RK
    Achievements, prospects and challenges in precision care for monogenic insulin-deficient and insulin-resistant diabetes.
    Diabetologia. 2022 May 27. pii: 10.1007/s00125-022-05720.
    >> Share

  413. ZHU R, Craciun I, Bernhards-Werge J, Jalo E, et al
    Age- and sex-specific effects of a long-term lifestyle intervention on body weight and cardiometabolic health markers in adults with prediabetes: results from the diabetes prevention study PREVIEW.
    Diabetologia. 2022 May 25. pii: 10.1007/s00125-022-05716.
    >> Share

  414. BRUZZANITI S, Piemonte E, Mozzillo E, Bruzzese D, et al
    High levels of blood circulating immune checkpoint molecules in children with new-onset type 1 diabetes are associated with the risk of developing an additional autoimmune disease.
    Diabetologia. 2022 May 25. pii: 10.1007/s00125-022-05724.
    >> Share

  415. ALSHEHRI Z, Subramanian A, Adderley NJ, Gokhale KM, et al
    Risk of incident obstructive sleep apnoea in patients with type 1 diabetes: a population-based retrospective cohort study.
    Diabetologia. 2022 May 24. pii: 10.1007/s00125-022-05714.
    >> Share

  416. WEI Y, Zhan Y, Lofvenborg JE, Tuomi T, et al
    Birthweight, BMI in adulthood and latent autoimmune diabetes in adults: a Mendelian randomisation study.
    Diabetologia. 2022 May 23. pii: 10.1007/s00125-022-05725.
    >> Share

  417. MERINO J
    Precision nutrition in diabetes: when population-based dietary advice gets personal.
    Diabetologia. 2022 May 20. pii: 10.1007/s00125-022-05721.
    >> Share

  418. PEARSON JA, Ding H, Hu C, Peng J, et al
    IgM-associated gut bacteria in obesity and type 2 diabetes in C57BL/6 mice and humans.
    Diabetologia. 2022 May 19. pii: 10.1007/s00125-022-05711.
    >> Share

  419. LIU J, Bai R, Chai Z, Cooper ME, et al
    Low- and middle-income countries demonstrate rapid growth of type 2 diabetes: an analysis based on Global Burden of Disease 1990-2019 data.
    Diabetologia. 2022 May 19. pii: 10.1007/s00125-022-05713.
    >> Share

  420. KARAGIANNIS T, Avgerinos I, Liakos A, Del Prato S, et al
    Management of type 2 diabetes with the dual GIP/GLP-1 receptor agonist tirzepatide: a systematic review and meta-analysis.
    Diabetologia. 2022 May 17. pii: 10.1007/s00125-022-05715.
    >> Share

  421. PEREA V, Picon MJ, Megia A, Goya M, et al
    Addition of intermittently scanned continuous glucose monitoring to standard care in a cohort of pregnant women with type 1 diabetes: effect on glycaemic control and pregnancy outcomes.
    Diabetologia. 2022 May 12. pii: 10.1007/s00125-022-05717.
    >> Share

  422. WOELFLE T, Linkohr B, Waterboer T, Thorand B, et al
    Health impact of seven herpesviruses on (pre)diabetes incidence and HbA1c: results from the KORA cohort.
    Diabetologia. 2022 May 11. pii: 10.1007/s00125-022-05704.
    >> Share

  423. KAWADA-HORITANI E, Kita S, Okita T, Nakamura Y, et al
    Human adipose-derived mesenchymal stem cells prevent type 1 diabetes induced by immune checkpoint blockade.
    Diabetologia. 2022 May 5. pii: 10.1007/s00125-022-05708.
    >> Share

  424. CHERNEY DZI, Charbonnel B, Cosentino F, Dagogo-Jack S, et al
    Ertugliflozin, renoprotection and potential confounding by muscle wasting. Reply to Groothof D, Post A, Gans ROB et al [letter].
    Diabetologia. 2022;65:908-911.
    >> Share

  425. PATARRAO RS, Duarte N, Coelho I, Ward J, et al
    Prediabetes blunts DPP4 genetic control of postprandial glycaemia and insulin secretion.
    Diabetologia. 2022;65:861-871.
    >> Share

  426. STARSKAIA I, Laajala E, Gronroos T, Harkonen T, et al
    Early DNA methylation changes in children developing beta cell autoimmunity at a young age.
    Diabetologia. 2022;65:844-860.
    >> Share

  427. DETTMER R, Niwolik I, Cirksena K, Yoshimoto T, et al
    Proinflammatory cytokines induce rapid, NO-independent apoptosis, expression of chemotactic mediators and interleukin-32 secretion in human pluripotent stem cell-derived beta cells.
    Diabetologia. 2022;65:829-843.
    >> Share

  428. GROOTHOF D, Post A, Gans ROB, Bakker SJL, et al
    Ertugliflozin, renoprotection and potential confounding by muscle wasting.
    Diabetologia. 2022;65:906-907.
    >> Share

    April 2022
  429. HUVINEN E, Lahti J, Klemetti MM, Bergman PH, et al
    Genetic risk of type 2 diabetes modifies the effects of a lifestyle intervention aimed at the prevention of gestational and postpartum diabetes.
    Diabetologia. 2022 Apr 30. pii: 10.1007/s00125-022-05712.
    >> Share

  430. WYATT RC, Hagopian WA, Roep BO, Patel KA, et al
    Congenital beta cell defects are not associated with markers of islet autoimmunity, even in the context of high genetic risk for type 1 diabetes.
    Diabetologia. 2022 Apr 30. pii: 10.1007/s00125-022-05697.
    >> Share

  431. KAMRATH C, Tittel SR, Dunstheimer D, Frohlich-Reiterer E, et al
    Early vs late histological confirmation of coeliac disease in children with new-onset type 1 diabetes.
    Diabetologia. 2022 Apr 30. pii: 10.1007/s00125-022-05701.
    >> Share

  432. ZHANG J, Chen Z, Parna K, van Zon SKR, et al
    Mediators of the association between educational attainment and type 2 diabetes mellitus: a two-step multivariable Mendelian randomisation study.
    Diabetologia. 2022 Apr 28. pii: 10.1007/s00125-022-05705.
    >> Share

  433. SIDDIQUI MK, Anjana RM, Dawed AY, Martoeau C, et al
    Correction to: Young-onset diabetes in Asian Indians is associated with lower measured and genetically determined beta cell function.
    Diabetologia. 2022 Apr 26. pii: 10.1007/s00125-022-05707.
    >> Share

  434. SOULIMANE S, Balkau B, Vogtschmidt YD, Toeller M, et al
    Incident cardiovascular disease by clustering of favourable risk factors in type 1 diabetes: the EURODIAB Prospective Complications Study.
    Diabetologia. 2022 Apr 12. pii: 10.1007/s00125-022-05698.
    >> Share

  435. PARK SK, Wang X, Ding N, Karvonen-Gutierrez CA, et al
    Per- and polyfluoroalkyl substances and incident diabetes in midlife women: the Study of Women's Health Across the Nation (SWAN).
    Diabetologia. 2022 Apr 11. pii: 10.1007/s00125-022-05695.
    >> Share

  436. WANG F, Baden MY, Guasch-Ferre M, Wittenbecher C, et al
    Plasma metabolite profiles related to plant-based diets and the risk of type 2 diabetes.
    Diabetologia. 2022 Apr 8. pii: 10.1007/s00125-022-05692.
    >> Share

  437. HERMANNS N, Ehrmann D, Shapira A, Kulzer B, et al
    Coordination of glucose monitoring, self-care behaviour and mental health: achieving precision monitoring in diabetes.
    Diabetologia. 2022 Apr 5. pii: 10.1007/s00125-022-05685.
    >> Share

  438. TIGCHELAAR C, van Zuylen ML, Hulst AH, Preckel B, et al
    Elevated cerebrospinal fluid glucose levels and diabetes mellitus are associated with activation of the neurotoxic polyol pathway.
    Diabetologia. 2022 Apr 5. pii: 10.1007/s00125-022-05693.
    >> Share

  439. THOMSEN MN, Astrup A, Holst JJ, Madsbad S, et al
    Long-term outcomes of dietary carbohydrate restriction for HbA1c reduction in type 2 diabetes mellitus are needed. Reply to Kang J and Ma E [letter].
    Diabetologia. 2022 Apr 1. pii: 10.1007/s00125-022-05689.
    >> Share

  440. KETTUNEN JLT, Rantala E, Dwivedi OP, Isomaa B, et al
    A multigenerational study on phenotypic consequences of the most common causal variant of HNF1A-MODY.
    Diabetologia. 2022;65:632-643.
    >> Share

    March 2022
  441. CHEN GC, Chai JC, Xing J, Moon JY, et al
    Healthful eating patterns, serum metabolite profile and risk of diabetes in a population-based prospective study of US Hispanics/Latinos.
    Diabetologia. 2022 Mar 31. pii: 10.1007/s00125-022-05690.
    >> Share

  442. KANG J, Ma E
    Long-term outcomes of dietary carbohydrate restriction for HbA1c reduction in type 2 diabetes mellitus are needed.
    Diabetologia. 2022 Mar 31. pii: 10.1007/s00125-022-05688.
    >> Share

  443. WANG H, Gou W, Su C, Du W, et al
    Association of gut microbiota with glycaemic traits and incident type 2 diabetes, and modulation by habitual diet: a population-based longitudinal cohort study in Chinese adults.
    Diabetologia. 2022 Mar 31. pii: 10.1007/s00125-022-05687.
    >> Share

  444. JACOB P, Potts L, Maclean RH, de Zoysa N, et al
    Characteristics of adults with type 1 diabetes and treatment-resistant problematic hypoglycaemia: a baseline analysis from the HARPdoc RCT.
    Diabetologia. 2022 Mar 24. pii: 10.1007/s00125-022-05679.
    >> Share

  445. CARLTON J, Leaviss J, Pouwer F, Hendrieckx C, et al
    Correction to: The suitability of patient-reported outcome measures used to assess the impact of hypoglycaemia on quality of life in people with diabetes: a systematic review using COSMIN methods.
    Diabetologia. 2022 Mar 23. pii: 10.1007/s00125-022-05668.
    >> Share

  446. BATISTA TM, Haider N, Kahn CR
    Correction to: Defining the underlying defect in insulin action in type 2 diabetes.
    Diabetologia. 2022 Mar 23. pii: 10.1007/s00125-022-05684.
    >> Share

  447. LEE K, Chan JY, Liang C, Ip CK, et al
    XBP1 maintains beta cell identity, represses beta-to-alpha cell transdifferentiation and protects against diabetic beta cell failure during metabolic stress in mice.
    Diabetologia. 2022 Mar 22. pii: 10.1007/s00125-022-05669.
    >> Share

  448. RUIZ PLD, Chen L, Morton JI, Salim A, et al
    Mortality trends in type 1 diabetes: a multicountry analysis of six population-based cohorts.
    Diabetologia. 2022 Mar 22. pii: 10.1007/s00125-022-05659.
    >> Share

  449. LING C
    Pharmacoepigenetics in type 2 diabetes: is it clinically relevant?
    Diabetologia. 2022 Mar 21. pii: 10.1007/s00125-022-05681.
    >> Share

  450. MULDER H, Fall T
    The COVID-19 pandemic may be receding but the diabetes pandemic rages on.
    Diabetologia. 2022 Mar 16. pii: 10.1007/s00125-022-05683.
    >> Share

  451. RATHMANN W, Kuss O, Kostev K
    Incidence of newly diagnosed diabetes after Covid-19.
    Diabetologia. 2022 Mar 16. pii: 10.1007/s00125-022-05670.
    >> Share

  452. DE SOUZA CORDEIRO LM, Bainbridge L, Devisetty N, McDougal DH, et al
    Loss of function of renal Glut2 reverses hyperglycaemia and normalises body weight in mouse models of diabetes and obesity.
    Diabetologia. 2022 Mar 15. pii: 10.1007/s00125-022-05676.
    >> Share

  453. ECHOUFFO-TCHEUGUI JB, Daya N, Ndumele CE, Matsushita K, et al
    Diabetes, GDF-15 and incident heart failure: the atherosclerosis risk in communities study.
    Diabetologia. 2022 Mar 11. pii: 10.1007/s00125-022-05678.
    >> Share

  454. BONHOF GJ, Strom A, Apostolopoulou M, Karusheva Y, et al
    High-intensity interval training for 12 weeks improves cardiovascular autonomic function but not somatosensory nerve function and structure in overweight men with type 2 diabetes.
    Diabetologia. 2022 Mar 11. pii: 10.1007/s00125-022-05674.
    >> Share

  455. SANCHEZ-RANGEL E, Gunawan F, Jiang L, Savoye M, et al
    Reversibility of brain glucose kinetics in type 2 diabetes mellitus.
    Diabetologia. 2022 Mar 5. pii: 10.1007/s00125-022-05664.
    >> Share

  456. SIDDIQUI MK, Anjana RM, Dawed AY, Martoeau C, et al
    Young-onset diabetes in Asian Indians is associated with lower measured and genetically determined beta cell function.
    Diabetologia. 2022 Mar 5. pii: 10.1007/s00125-022-05671.
    >> Share

  457. FEVE B, Scheen AJ
    When therapeutic drugs lead to diabetes.
    Diabetologia. 2022 Mar 4. pii: 10.1007/s00125-022-05666.
    >> Share

  458. DOWNIE CG, Dimos SF, Bien SA, Hu Y, et al
    Multi-ethnic GWAS and fine-mapping of glycaemic traits identify novel loci in the PAGE Study.
    Diabetologia. 2022;65:477-489.
    >> Share

  459. GRAJALES D, Vazquez P, Ruiz-Rosario M, Tuduri E, et al
    The second-generation antipsychotic drug aripiprazole modulates the serotonergic system in pancreatic islets and induces beta cell dysfunction in female mice.
    Diabetologia. 2022;65:490-505.
    >> Share

    February 2022
  460. QIU Y, Buffonge S, Ramnath R, Jenner S, et al
    Endothelial glycocalyx is damaged in diabetic cardiomyopathy: angiopoietin 1 restores glycocalyx and improves diastolic function in mice.
    Diabetologia. 2022 Feb 25. pii: 10.1007/s00125-022-05650.
    >> Share

  461. SU MH, Shih YH, Lin YF, Chen PC, et al
    Familial aggregation and shared genetic loading for major psychiatric disorders and type 2 diabetes.
    Diabetologia. 2022 Feb 23. pii: 10.1007/s00125-022-05665.
    >> Share

  462. BENITEZ-AGUIRRE PZ, Marcovecchio ML, Chiesa ST, Craig ME, et al
    Urinary albumin/creatinine ratio tertiles predict risk of diabetic retinopathy progression: a natural history study from the Adolescent Cardio-Renal Intervention Trial (AdDIT) observational cohort.
    Diabetologia. 2022 Feb 19. pii: 10.1007/s00125-022-05661.
    >> Share

  463. FRASZCZYK E, Spijkerman AMW, Zhang Y, Brandmaier S, et al
    Epigenome-wide association study of incident type 2 diabetes: a meta-analysis of five prospective European cohorts.
    Diabetologia. 2022 Feb 15. pii: 10.1007/s00125-022-05652.
    >> Share

  464. JENKINS AJ, Grant MB, Busik JV
    Lipids, hyperreflective crystalline deposits and diabetic retinopathy: potential systemic and retinal-specific effect of lipid-lowering therapies.
    Diabetologia. 2022 Feb 11. pii: 10.1007/s00125-022-05655.
    >> Share

  465. TEO E, Hassan N, Tam W, Koh S, et al
    Effectiveness of continuous glucose monitoring in maintaining glycaemic control among people with type 1 diabetes mellitus: a systematic review of randomised controlled trials and meta-analysis.
    Diabetologia. 2022 Feb 9. pii: 10.1007/s00125-021-05648.
    >> Share

  466. KIBIRIGE D, Sekitoleko I, Lumu W, Jones AG, et al
    Understanding the pathogenesis of lean non-autoimmune diabetes in an African population with newly diagnosed diabetes.
    Diabetologia. 2022 Feb 9. pii: 10.1007/s00125-021-05644.
    >> Share

  467. TUCHMAN AM
    One size does not fit all: an historian's perspective on precision diabetes medicine.
    Diabetologia. 2022 Feb 8. pii: 10.1007/s00125-022-05660.
    >> Share

  468. WALKER VM, Vujkovic M, Carter AR, Davies NM, et al
    Separating the direct effects of traits on atherosclerotic cardiovascular disease from those mediated by type 2 diabetes.
    Diabetologia. 2022 Feb 7. pii: 10.1007/s00125-022-05653.
    >> Share

  469. VANDERCAPPELLEN EJ, Koster A, Savelberg HHCM, Eussen SJPM, et al
    Sedentary behaviour and physical activity are associated with biomarkers of endothelial dysfunction and low-grade inflammation-relevance for (pre)diabetes: The Maastricht Study.
    Diabetologia. 2022 Feb 4. pii: 10.1007/s00125-022-05651.
    >> Share

  470. MIETTINEN ME, Honkanen J, Niinisto S, Vaarala O, et al
    Breastfeeding and circulating immunological markers during the first 3 years of life: the DIABIMMUNE study.
    Diabetologia. 2022;65:329-335.
    >> Share

    January 2022
  471. MOYCE GRUBER BL, Cole LK, Xiang B, Fonseca MA, et al
    Adiponectin deficiency induces hepatic steatosis during pregnancy and gestational diabetes in mice.
    Diabetologia. 2022 Jan 28. pii: 10.1007/s00125-021-05649.
    >> Share

  472. ZHAO JV, Liu F, Schooling CM, Li J, et al
    Using genetics to assess the association of commonly used antihypertensive drugs with diabetes, glycaemic traits and lipids: a trans-ancestry Mendelian randomisation study.
    Diabetologia. 2022 Jan 26. pii: 10.1007/s00125-021-05645.
    >> Share

  473. KHAN KS, Overgaard K, Tankisi H, Karlsson P, et al
    Effects of progressive resistance training in individuals with type 2 diabetic polyneuropathy: a randomised assessor-blinded controlled trial.
    Diabetologia. 2022 Jan 19. pii: 10.1007/s00125-021-05646.
    >> Share

  474. MURTHY VL, Nayor M, Carnethon M, Reis JP, et al
    Circulating metabolite profile in young adulthood identifies long-term diabetes susceptibility: the Coronary Artery Risk Development in Young Adults (CARDIA) study.
    Diabetologia. 2022 Jan 18. pii: 10.1007/s00125-021-05641.
    >> Share

  475. SO M, O'Rourke C, Ylescupidez A, Bahnson HT, et al
    Characterising the age-dependent effects of risk factors on type 1 diabetes progression.
    Diabetologia. 2022 Jan 18. pii: 10.1007/s00125-021-05647.
    >> Share

  476. DZIOPA K, Asselbergs FW, Gratton J, Chaturvedi N, et al
    Cardiovascular risk prediction in type 2 diabetes: a comparison of 22 risk scores in primary care settings.
    Diabetologia. 2022 Jan 15. pii: 10.1007/s00125-021-05640.
    >> Share

  477. HO KL, Karwi QG, Connolly D, Pherwani S, et al
    Metabolic, structural and biochemical changes in diabetes and the development of heart failure.
    Diabetologia. 2022 Jan 7. pii: 10.1007/s00125-021-05637.
    >> Share

  478. THOMSEN MN, Skytte MJ, Samkani A, Carl MH, et al
    Dietary carbohydrate restriction augments weight loss-induced improvements in glycaemic control and liver fat in individuals with type 2 diabetes: a randomised controlled trial.
    Diabetologia. 2022 Jan 7. pii: 10.1007/s00125-021-05628.
    >> Share

  479. SORENSEN TIA, Metz S, Kilpelainen TO
    Do gene-environment interactions have implications for the precision prevention of type 2 diabetes?
    Diabetologia. 2022 Jan 7. pii: 10.1007/s00125-021-05639.
    >> Share

  480. HERDER C, Roden M
    A novel diabetes typology: towards precision diabetology from pathogenesis to treatment.
    Diabetologia. 2022 Jan 4. pii: 10.1007/s00125-021-05625.
    >> Share

  481. XIONG L, Chen L, Wu L, He W, et al
    Lipotoxicity-induced circGlis3 impairs beta cell function and is transmitted by exosomes to promote islet endothelial cell dysfunction.
    Diabetologia. 2022;65:188-205.
    >> Share

    December 2021
  482. BOCHKUR DRATVER MA, Arenas J, Thaweethai T, Yu C, et al
    Longitudinal changes in glucose during pregnancy in women with gestational diabetes risk factors.
    Diabetologia. 2021 Dec 30. pii: 10.1007/s00125-021-05622.
    >> Share

  483. SLUIMAN AJ, McLachlan S, Forster RB, Strachan MWJ, et al
    Higher baseline inflammatory marker levels predict greater cognitive decline in older people with type 2 diabetes: year 10 follow-up of the Edinburgh Type 2 Diabetes Study.
    Diabetologia. 2021 Dec 21. pii: 10.1007/s00125-021-05634.
    >> Share

  484. QUESADA-MASACHS E, Zilberman S, Rajendran S, Chu T, et al
    Upregulation of HLA class II in pancreatic beta cells from organ donors with type 1 diabetes.
    Diabetologia. 2021 Dec 21. pii: 10.1007/s00125-021-05619.
    >> Share

  485. YANG S, Yang G, Wu H, Kang L, et al
    MicroRNA-193b impairs muscle growth in mouse models of type 2 diabetes by targeting the PDK1/Akt signalling pathway.
    Diabetologia. 2021 Dec 16. pii: 10.1007/s00125-021-05616.
    >> Share

  486. STRELITZ J, Lawlor ER, Wu Y, Estlin A, et al
    Association between weight change and incidence of cardiovascular disease events and mortality among adults with type 2 diabetes: a systematic review of observational studies and behavioural intervention trials.
    Diabetologia. 2021 Dec 2. pii: 10.1007/s00125-021-05605.
    >> Share

  487. HOLT RIG, DeVries JH, Hess-Fischl A, Hirsch IB, et al
    Correction to: The management of type 1 diabetes in adults. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).
    Diabetologia. 2021 Dec 1. pii: 10.1007/s00125-021-05600.
    >> Share

  488. LIN DS, Lee JK, Hung CS, Chen WJ, et al
    The efficacy and safety of novel classes of glucose-lowering drugs for cardiovascular outcomes: a network meta-analysis of randomised clinical trials.
    Diabetologia. 2021;64:2676-2686.
    >> Share

  489. REMIE CME, Janssens GE, Bilet L, van Weeghel M, et al
    Sitting less elicits metabolic responses similar to exercise and enhances insulin sensitivity in postmenopausal women.
    Diabetologia. 2021;64:2817-2828.
    >> Share

  490. KARHUNEN V, Daghlas I, Zuber V, Vujkovic M, et al
    Leveraging human genetic data to investigate the cardiometabolic effects of glucose-dependent insulinotropic polypeptide signalling.
    Diabetologia. 2021;64:2773-2778.
    >> Share

    November 2021
  491. LINDEKILDE N, Scheuer SH, Rutters F, Knudsen L, et al
    Prevalence of type 2 diabetes in psychiatric disorders: an umbrella review with meta-analysis of 245 observational studies from 32 systematic reviews.
    Diabetologia. 2021 Nov 29. pii: 10.1007/s00125-021-05609.
    >> Share

  492. ALI MK, Pearson-Stuttard J, Selvin E, Gregg EW, et al
    Interpreting global trends in type 2 diabetes complications and mortality.
    Diabetologia. 2021 Nov 27. pii: 10.1007/s00125-021-05585.
    >> Share

  493. PRASAD RB, Asplund O, Shukla SR, Wagh R, et al
    Correction to: Subgroups of patients with young-onset type 2 diabetes in India reveal insulin deficiency as a major driver.
    Diabetologia. 2021 Nov 22. pii: 10.1007/s00125-021-05620.
    >> Share

  494. CHENG F, Luk AO, Wu H, Tam CHT, et al
    Relative leucocyte telomere length is associated with incident end-stage kidney disease and rapid decline of kidney function in type 2 diabetes: analysis from the Hong Kong Diabetes Register.
    Diabetologia. 2021 Nov 22. pii: 10.1007/s00125-021-05613.
    >> Share

  495. PRESTON FG, Meng Y, Burgess J, Ferdousi M, et al
    Artificial intelligence utilising corneal confocal microscopy for the diagnosis of peripheral neuropathy in diabetes mellitus and prediabetes.
    Diabetologia. 2021 Nov 21. pii: 10.1007/s00125-021-05617.
    >> Share

  496. GRUBER N, Rathaus M, Ron I, Livne R, et al
    Fatty acid-binding protein 4: a key regulator of ketoacidosis in new-onset type 1 diabetes.
    Diabetologia. 2021 Nov 21. pii: 10.1007/s00125-021-05606.
    >> Share

  497. CHEN S, Zong G, Wu Q, Yun H, et al
    Associations of plasma glycerophospholipid profile with modifiable lifestyles and incident diabetes in middle-aged and older Chinese.
    Diabetologia. 2021 Nov 20. pii: 10.1007/s00125-021-05611.
    >> Share

  498. SOKOOTI S, Flores-Guerrero JL, Heerspink HJL, Garcia E, et al
    Lipoprotein particle sizes and incident type 2 diabetes: the PREVEND cohort study.
    Diabetologia. 2021 Nov 20. pii: 10.1007/s00125-021-05603.
    >> Share

  499. MAALMI H, Herder C, Bonhof GJ, Strassburger K, et al
    Differences in the prevalence of erectile dysfunction between novel subgroups of recent-onset diabetes.
    Diabetologia. 2021 Nov 20. pii: 10.1007/s00125-021-05607.
    >> Share

  500. BEULENS JWJ, Pinho MGM, Abreu TC, den Braver NR, et al
    Environmental risk factors of type 2 diabetes-an exposome approach.
    Diabetologia. 2021 Nov 18. pii: 10.1007/s00125-021-05618.
    >> Share

  501. CHURUANGSUK C, Hall J, Reynolds A, Griffin SJ, et al
    Diets for weight management in adults with type 2 diabetes: an umbrella review of published meta-analyses and systematic review of trials of diets for diabetes remission.
    Diabetologia. 2021 Nov 17. pii: 10.1007/s00125-021-05577.
    >> Share

  502. SECHER AL, Pedersen-Bjergaard U, Svendsen OL, Gade-Rasmussen B, et al
    Correction to: Flash glucose monitoring and automated bolus calculation in type 1 diabetes treated with multiple daily insulin injections: a 26 week randomised, controlled, multicentre trial.
    Diabetologia. 2021 Nov 15. pii: 10.1007/s00125-021-05601.
    >> Share

  503. SPEIGHT J, Skinner TC, Huber JW, Lake AJ, et al
    A PSAD Group response to the consensus report on the definition and interpretation of remission in type 2 diabetes: a psychosocial perspective is needed.
    Diabetologia. 2021 Nov 15. pii: 10.1007/s00125-021-05615.
    >> Share

  504. SUGIYAMA K, Saisho Y
    Predicting non-insulin-dependent state in patients with slowly progressive insulin-dependent (type 1) diabetes mellitus or latent autoimmune diabetes in adults.
    Diabetologia. 2021 Nov 11. pii: 10.1007/s00125-021-05602.
    >> Share

  505. WADA E, Onoue T, Kinoshita T, Hayase A, et al
    Predicting non-insulin-dependent state in patients with slowly progressive insulin-dependent (type 1) diabetes mellitus or latent autoimmune diabetes in adults. Reply to Sugiyama K and Saisho Y [letter].
    Diabetologia. 2021 Nov 11. pii: 10.1007/s00125-021-05610.
    >> Share

  506. DRAKE I, Fryk E, Strindberg L, Lundqvist A, et al
    The role of circulating galectin-1 in type 2 diabetes and chronic kidney disease: evidence from cross-sectional, longitudinal and Mendelian randomisation analyses.
    Diabetologia. 2021 Nov 7. pii: 10.1007/s00125-021-05594.
    >> Share

  507. STOTL I, Blagus R, Urbancic-Rovan V
    Individualised screening of diabetic foot: creation of a prediction model based on penalised regression and assessment of theoretical efficacy.
    Diabetologia. 2021 Nov 6. pii: 10.1007/s00125-021-05604.
    >> Share

  508. YAMAMOTO Y, Hanai K, Mori T, Yokoyama Y, et al
    Kidney outcomes and all-cause mortality in people with type 2 diabetes exhibiting non-albuminuric kidney insufficiency.
    Diabetologia. 2021 Nov 5. pii: 10.1007/s00125-021-05590.
    >> Share

  509. AMIRRUDDIN NS, Tan WX, Tan YS, Gardner DS, et al
    Progressive endoplasmic reticulum stress over time due to human insulin gene mutation contributes to pancreatic beta cell dysfunction.
    Diabetologia. 2021;64:2534-2549.
    >> Share

  510. VANDEWALLE J, Van der Auwera BJ, Amin H, Quartier E, et al
    Genetic variation at ERBB3/IKZF4 and sexual dimorphism in epitope spreading in single autoantibody-positive relatives.
    Diabetologia. 2021;64:2511-2516.
    >> Share

  511. YOUNG TK, Li JW, Kang A, Heerspink HJL, et al
    Effects of canagliflozin compared with placebo on major adverse cardiovascular and kidney events in patient groups with different baseline levels of HbA1c, disease duration and treatment intensity: results from the CANVAS Program.
    Diabetologia. 2021;64:2402-2414.
    >> Share

    October 2021
  512. SCHLESINGER S, Neuenschwander M, Barbaresko J, Lang A, et al
    Prediabetes and risk of mortality, diabetes-related complications and comorbidities: umbrella review of meta-analyses of prospective studies.
    Diabetologia. 2021 Oct 31. pii: 10.1007/s00125-021-05592.
    >> Share

  513. CHARLES MH, Thomsen JL, Christensen B, Pulleyblank R, et al
    Use of electronic patient data overview with alerts in primary care increases prescribing of lipid-lowering medications in patients with type 2 diabetes.
    Diabetologia. 2021 Oct 28. pii: 10.1007/s00125-021-05598.
    >> Share

  514. CEREIJO L, Gullon P, Del Cura I, Valades D, et al
    Exercise facilities and the prevalence of obesity and type 2 diabetes in the city of Madrid.
    Diabetologia. 2021 Oct 28. pii: 10.1007/s00125-021-05582.
    >> Share

  515. BOLDISON J, Long AE, Aitken RJ, Wilson IV, et al
    Activated but functionally impaired memory Tregs are expanded in slow progressors to type 1 diabetes.
    Diabetologia. 2021 Oct 28. pii: 10.1007/s00125-021-05595.
    >> Share

  516. HELLER SR, Geybels MS, Iqbal A, Liu L, et al
    A higher non-severe hypoglycaemia rate is associated with an increased risk of subsequent severe hypoglycaemia and major adverse cardiovascular events in individuals with type 2 diabetes in the LEADER study.
    Diabetologia. 2021 Oct 26. pii: 10.1007/s00125-021-05556.
    >> Share

  517. THOMAS NJ, Dennis JM, Sharp SA, Kaur A, et al
    Correction to: DR15-DQ6 remains dominantly protective against type 1 diabetes throughout the first five decades of life.
    Diabetologia. 2021 Oct 26. pii: 10.1007/s00125-021-05599.
    >> Share

  518. VETRANI C, Calabrese I, Cavagnuolo L, Pacella D, et al
    Dietary determinants of postprandial blood glucose control in adults with type 1 diabetes on a hybrid closed-loop system.
    Diabetologia. 2021 Oct 23. pii: 10.1007/s00125-021-05587.
    >> Share

  519. PRASAD RB, Asplund O, Shukla SR, Wagh R, et al
    Subgroups of patients with young-onset type 2 diabetes in India reveal insulin deficiency as a major driver.
    Diabetologia. 2021 Oct 23. pii: 10.1007/s00125-021-05543.
    >> Share

  520. PATEL KA, Ozbek MN, Yildiz M, Guran T, et al
    Systematic genetic testing for recessively inherited monogenic diabetes: a cross-sectional study in paediatric diabetes clinics.
    Diabetologia. 2021 Oct 23. pii: 10.1007/s00125-021-05597.
    >> Share

  521. MUTTER S, Valo E, Aittomaki V, Nybo K, et al
    Urinary metabolite profiling and risk of progression of diabetic nephropathy in 2670 individuals with type 1 diabetes.
    Diabetologia. 2021 Oct 22. pii: 10.1007/s00125-021-05584.
    >> Share

  522. LEMIEUX P, Benham JL, Donovan LE, Moledina N, et al
    The association between gestational diabetes and stillbirth: a systematic review and meta-analysis.
    Diabetologia. 2021 Oct 21. pii: 10.1007/s00125-021-05579.
    >> Share

  523. PIGEYRE M, Hess S, Gomez MF, Asplund O, et al
    Validation of the classification for type 2 diabetes into five subgroups: a report from the ORIGIN trial.
    Diabetologia. 2021 Oct 21. pii: 10.1007/s00125-021-05567.
    >> Share

  524. FARMAKI AE, Garfield V, Eastwood SV, Farmer RE, et al
    Type 2 diabetes risks and determinants in second-generation migrants and mixed ethnicity people of South Asian and African Caribbean descent in the UK.
    Diabetologia. 2021 Oct 20. pii: 10.1007/s00125-021-05580.
    >> Share

  525. AGYEMANG C, van der Linden EL, Bennet L
    Type 2 diabetes burden among migrants in Europe: unravelling the causal pathways.
    Diabetologia. 2021 Oct 16. pii: 10.1007/s00125-021-05586.
    >> Share

  526. JESUTHASAN A, Zhyzhneuskaya S, Peters C, Barnes AC, et al
    Sex differences in intraorgan fat levels and hepatic lipid metabolism: implications for cardiovascular health and remission of type 2 diabetes after dietary weight loss.
    Diabetologia. 2021 Oct 16. pii: 10.1007/s00125-021-05583.
    >> Share

  527. BENHALIMA K, van Nes F, Laenen A, Gillard P, et al
    Risk for ketonaemia in type 1 diabetes pregnancies with sensor-augmented pump therapy with predictive low glucose suspend compared with low glucose suspend: a crossover RCT.
    Diabetologia. 2021 Oct 13. pii: 10.1007/s00125-021-05589.
    >> Share

  528. FELTON JL, Cuthbertson D, Warnock M, Lohano K, et al
    HOMA2-B enhances assessment of type 1 diabetes risk among TrialNet Pathway to Prevention participants.
    Diabetologia. 2021 Oct 12. pii: 10.1007/s00125-021-05573.
    >> Share

  529. MORGENSTERN J, Groener JB, Jende JME, Kurz FT, et al
    Correction to: Neuron-specific biomarkers predict hypo- and hyperalgesia in individuals with diabetic peripheral neuropathy.
    Diabetologia. 2021 Oct 11. pii: 10.1007/s00125-021-05588.
    >> Share

  530. LOCKE JM, Dusatkova P, Colclough K, Hughes AE, et al
    Association of birthweight and penetrance of diabetes in individuals with HNF4A-MODY: a cohort study.
    Diabetologia. 2021 Oct 7. pii: 10.1007/s00125-021-05581.
    >> Share

  531. JEYAM A, Gibb FW, McKnight JA, O'Reilly JE, et al
    Flash monitor initiation is associated with improvements in HbA1c levels and DKA rates among people with type 1 diabetes in Scotland: a retrospective nationwide observational study.
    Diabetologia. 2021 Oct 7. pii: 10.1007/s00125-021-05578.
    >> Share

  532. GREEN A, Hede SM, Patterson CC, Wild SH, et al
    Type 1 diabetes in 2017: global estimates of incident and prevalent cases in children and adults.
    Diabetologia. 2021 Oct 2. pii: 10.1007/s00125-021-05571.
    >> Share

  533. SEN T, Li J, Neuen BL, Neal B, et al
    Effects of the SGLT2 inhibitor canagliflozin on plasma biomarkers TNFR-1, TNFR-2 and KIM-1 in the CANVAS trial.
    Diabetologia. 2021;64:2147-2158.
    >> Share

  534. PERNG W, Kelsey MM, Sauder KA, Dabelea D, et al
    How does exposure to overnutrition in utero lead to childhood adiposity? Testing the insulin hypersecretion hypothesis in the EPOCH cohort.
    Diabetologia. 2021;64:2237-2246.
    >> Share

  535. UEDA P, Wintzell V, Melbye M, Eliasson B, et al
    Use of incretin-based drugs and risk of cholangiocarcinoma: Scandinavian cohort study.
    Diabetologia. 2021;64:2204-2214.
    >> Share

  536. JENSEN MH, Hejlesen O, Vestergaard P
    Epidemiology of hypoglycaemic episodes leading to hospitalisations in Denmark in 1998-2018.
    Diabetologia. 2021;64:2193-2203.
    >> Share

    September 2021
  537. BARROSO I
    The importance of increasing population diversity in genetic studies of type 2 diabetes and related glycaemic traits.
    Diabetologia. 2021 Sep 30. pii: 10.1007/s00125-021-05575.
    >> Share

  538. HOLT RIG, DeVries JH, Hess-Fischl A, Hirsch IB, et al
    The management of type 1 diabetes in adults. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).
    Diabetologia. 2021 Sep 30. pii: 10.1007/s00125-021-05568.
    >> Share

  539. RUSSELL RD, Roberts-Thomson KM, Hu D, Greenaway T, et al
    Impaired postprandial skeletal muscle vascular responses to a mixed meal challenge in normoglycaemic people with a parent with type 2 diabetes.
    Diabetologia. 2021 Sep 29. pii: 10.1007/s00125-021-05572.
    >> Share

  540. SIDDIQUI MK, Smith G, St Jean P, Dawed AY, et al
    Diabetes status modifies the long-term effect of lipoprotein-associated phospholipase A2 on major coronary events.
    Diabetologia. 2021 Sep 25. pii: 10.1007/s00125-021-05574.
    >> Share

  541. SJOGREN RJO, Rizo-Roca D, Chibalin AV, Chorell E, et al
    Branched-chain amino acid metabolism is regulated by ERRalpha in primary human myotubes and is further impaired by glucose loading in type 2 diabetes.
    Diabetologia. 2021;64:2077-2091.
    >> Share

  542. QIAN B, Yang Y, Tang N, Wang J, et al
    M1 macrophage-derived exosomes impair beta cell insulin secretion via miR-212-5p by targeting SIRT2 and inhibiting Akt/GSK-3beta/beta-catenin pathway in mice.
    Diabetologia. 2021;64:2037-2051.
    >> Share

  543. MOHOLDT T, Parr EB, Devlin BL, Debik J, et al
    The effect of morning vs evening exercise training on glycaemic control and serum metabolites in overweight/obese men: a randomised trial.
    Diabetologia. 2021;64:2061-2076.
    >> Share

    August 2021
  544. HENRIKSEN MM, Andersen HU, Thorsteinsson B, Pedersen-Bjergaard U, et al
    Does nocturnal hypoglycaemia really improve quality of life? Reply to Soholm U, Broadley MM, Choudhary P et al [letter].
    Diabetologia. 2021;64:1895-1896.
    >> Share

  545. FOREMAN YD, van Doorn WPTM, Schaper NC, van Greevenbroek MMJ, et al
    Greater daily glucose variability and lower time in range assessed with continuous glucose monitoring are associated with greater aortic stiffness: The Maastricht Study.
    Diabetologia. 2021;64:1880-1892.
    >> Share

  546. REID LJ, Gibb FW, Colhoun H, Wild SH, et al
    Continuous subcutaneous insulin infusion therapy is associated with reduced retinopathy progression compared with multiple daily injections of insulin.
    Diabetologia. 2021;64:1725-1736.
    >> Share

  547. SCHNURR TM, Jorsboe E, Chadt A, Dahl-Petersen IK, et al
    Physical activity attenuates postprandial hyperglycaemia in homozygous TBC1D4 loss-of-function mutation carriers.
    Diabetologia. 2021;64:1795-1804.
    >> Share

    July 2021
  548. GASTALDELLI A, Stefan N, Haring HU
    Liver-targeting drugs and their effect on blood glucose and hepatic lipids.
    Diabetologia. 2021;64:1461-1479.
    >> Share

  549. BENN M, Emanuelsson F, Tybjaerg-Hansen A, Nordestgaard BG, et al
    Impact of high glucose levels and glucose lowering on risk of ischaemic stroke: a Mendelian randomisation study and meta-analysis.
    Diabetologia. 2021;64:1492-1503.
    >> Share

  550. KRISTENSEN KB, Henriksen DP, Hallas J, Pottegard A, et al
    Sodium-glucose cotransporter 2 inhibitors and risk of nephrolithiasis.
    Diabetologia. 2021;64:1563-1571.
    >> Share

    June 2021
  551. FRANCIS EC, Dabelea D, Perng W
    Impact of maternal HbA1c on offspring glucose at 4-7 years of age: role of childhood adiposity and other potential confounders. Reply to Periyathambi N, Sukumar N, Weldeselassie Y, Saravanan P [letter].
    Diabetologia. 2021;64:1449-1450.
    >> Share

  552. PERIYATHAMBI N, Sukumar N, Weldeselassie Y, Saravanan P, et al
    Impact of maternal HbA1c on offspring glucose at 4-7 years of age: role of childhood adiposity and other potential confounders.
    Diabetologia. 2021;64:1447-1448.
    >> Share

  553. GERST F, Kemter E, Lorza-Gil E, Kaiser G, et al
    The hepatokine fetuin-A disrupts functional maturation of pancreatic beta cells.
    Diabetologia. 2021;64:1358-1374.
    >> Share

  554. RATHMANN W, Bongaerts B
    Pharmacogenetics of novel glucose-lowering drugs.
    Diabetologia. 2021;64:1201-1212.
    >> Share

    May 2021
  555. MARSHALL SM
    Celebrating 100 years of insulin.
    Diabetologia. 2021;64:944-946.
    >> Share

  556. JAROSINSKI MA, Dhayalan B, Rege N, Chatterjee D, et al
    'Smart' insulin-delivery technologies and intrinsic glucose-responsive insulin analogues.
    Diabetologia. 2021;64:1016-1029.
    >> Share

  557. AMIEL SA
    The consequences of hypoglycaemia.
    Diabetologia. 2021;64:963-970.
    >> Share

  558. BOUGHTON CK, Hovorka R
    New closed-loop insulin systems.
    Diabetologia. 2021;64:1007-1015.
    >> Share

  559. NATHAN DM
    Realising the long-term promise of insulin therapy: the DCCT/EDIC study.
    Diabetologia. 2021;64:1049-1058.
    >> Share

  560. YOON NA, Diano S
    Hypothalamic glucose-sensing mechanisms.
    Diabetologia. 2021;64:985-993.
    >> Share

  561. BERAN D, Lazo-Porras M, Mba CM, Mbanya JC, et al
    A global perspective on the issue of access to insulin.
    Diabetologia. 2021;64:954-962.
    >> Share

  562. MELTON D
    The promise of stem cell-derived islet replacement therapy.
    Diabetologia. 2021;64:1030-1036.
    >> Share

  563. MATHIEU C
    Minimising hypoglycaemia in the real world: the challenge of insulin.
    Diabetologia. 2021;64:978-984.
    >> Share

    April 2021
  564. MOSER O, Riddell MC, Eckstein ML, Adolfsson P, et al
    Glucose management for exercise using continuous glucose monitoring: should sex and prandial state be additional considerations? Reply to Yardley JE and Sigal RJ [letter].
    Diabetologia. 2021;64:935-938.
    >> Share

  565. YARDLEY JE, Sigal RJ
    Glucose management for exercise using continuous glucose monitoring: should sex and prandial state be additional considerations?
    Diabetologia. 2021;64:932-934.
    >> Share

  566. HUGHES AE, Hattersley AT, Flanagan SE, Freathy RM, et al
    Two decades since the fetal insulin hypothesis: what have we learned from genetics?
    Diabetologia. 2021;64:717-726.
    >> Share

  567. FABRICIUS TW, Verhulst CEM, Kristensen PL, Tack CJ, et al
    Hyperinsulinaemic-hypoglycaemic glucose clamps in human research: a systematic review of the literature.
    Diabetologia. 2021;64:727-736.
    >> Share

  568. AKAZAWA S, Mackin L, Jhala G, Fynch S, et al
    Deficiency of the innate immune adaptor STING promotes autoreactive T cell expansion in NOD mice.
    Diabetologia. 2021;64:878-889.
    >> Share

    March 2021
  569. AMIYA T, Nakamoto N, Irie J, Taniki N, et al
    C-C motif chemokine receptor 9 regulates obesity-induced insulin resistance via inflammation of the small intestine in mice.
    Diabetologia. 2021;64:603-617.
    >> Share

    February 2021
  570. HOUZELLE A, Jorgensen JA, Schaart G, Daemen S, et al
    Human skeletal muscle mitochondrial dynamics in relation to oxidative capacity and insulin sensitivity.
    Diabetologia. 2021;64:424-436.
    >> Share

  571. ELEFTHERIADOU A, Williams S, Nevitt S, Brown E, et al
    The prevalence of cardiac autonomic neuropathy in prediabetes: a systematic review.
    Diabetologia. 2021;64:288-303.
    >> Share

  572. MADSEN LR, Gibbons KS, Ma RCW, Tam WH, et al
    Do variations in insulin sensitivity and insulin secretion in pregnancy predict differences in obstetric and neonatal outcomes?
    Diabetologia. 2021;64:304-312.
    >> Share

  573. PILMARK NS, Lyngbaek M, Oberholzer L, Elkjaer I, et al
    The interaction between metformin and physical activity on postprandial glucose and glucose kinetics: a randomised, clinical trial.
    Diabetologia. 2021;64:397-409.
    >> Share

    January 2021
  574. MULDER H
    The times they are a-changin'.
    Diabetologia. 2021;64:3-4.
    >> Share

  575. KAHN D, Perreault L, Macias E, Zarini S, et al
    Subcellular localisation and composition of intramuscular triacylglycerol influence insulin sensitivity in humans.
    Diabetologia. 2021;64:168-180.
    >> Share

  576. FAERCH K, Blond MB, Bruhn L, Amadid H, et al
    The effects of dapagliflozin, metformin or exercise on glycaemic variability in overweight or obese individuals with prediabetes (the PRE-D Trial): a multi-arm, randomised, controlled trial.
    Diabetologia. 2021;64:42-55.
    >> Share

    May 2020
  577. CHE D, Fang Z, Yan L, Du J, et al
    Elevated pigment epithelium-derived factor induces diabetic erectile dysfunction via interruption of the Akt/Hsp90beta/eNOS complex.
    Diabetologia. 2020 May 6. pii: 10.1007/s00125-020-05147.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016